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ABSTRACT

APPLICATION OF SPECIATED ISOTOPE DILUTION MASS SPECTROMETRY TO
THE ASSESSMENT OF HUMAN HEALTH AND TOXIC EXPOSURE

By
Timothy M. Fahrenholz
December 2011

Dissertation supervised by Professor H. M. “Skip” Kingston

Previous work by our research group demonstrated that quantitative chemical
analysis of analytes, such as mercury and chromium species, in environmental matrices
could be successfully carried out without using calibration curves and with correction for
species interconversion by using EPA Method 6800A. This method encompasses isotope
dilution mass spectrometry (IDMS) and speciated isotope dilution mass spectrometry
(SIDMS), both of which are described in detail in chapter 1. Research described in this
dissertation expands upon our earlier work by applying the method to the speciation of
mercury in biological matrices, the speciation of glutathione in red blood cells and whole
blood, and the analysis of enzyme activity in mammalian tissue.
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For example, in an experiment involving mercury speciation in a hair sample
(chapter 2), EPA Method 6800A corrected for the conversion of over 70% of the
C2H5Hg+ to Hg2+, as well as other conversions that occurred, so that the correct
concentrations of all mercury species present could be obtained.
EPA Method 6800A was also used for the analysis of glutathione in red blood
cells in two autism studies (chapter 3). In one of the studies, analysis of 16 matched pairs
of control and autistic samples demonstrated that red blood cell total glutathione
concentrations were higher in samples from autistic patients than ones from controls
(p=0.012), suggesting that the autistic patients studied may be making more glutathione
in response to a larger toxic burden of heavy metals such as lead, antimony, aluminum,
and cadmium, compared to controls.
Another application of EPA Method 6800A involved the analysis of alpha –
Galactosidase A (GLA) activity in liver, kidney, and brain tissues harvested from mice as
part of the development of a gene therapy animal model for Fabry’s disease (chapter 4).
In this study, EPA Method 6800A successfully distinguished between samples from gene
deficient and wild type mice, as well as mice exposed to two different dosages for gene
therapy treatment.
The successful application of EPA Method 6800A in biological matrices
described in this dissertation should serve to foster further usage of it in fields such as
medicine, toxicology, and agriculture.
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Introduction: Human Environmental Health and The Importance of Mercury and
Glutathione Speciation: the toxicant and immune system

Environmental health is a relatively new field, and yet it has been known
anecdotally for decades and is a result of our industrial revolution that has forever altered
our environment. There is great concern about how toxicants which are being introduced
into the environment are impacting lifespans and the quality of people’s lives. Of the over
80,000 chemicals registered with the U.S. Environmental Protection Agency, only about
200 have undergone extensive testing for neurotoxicity (1). It has been suggested by the
National Academy of Sciences that 3% of developmental disorders may be attributed to
exposure to environmental toxicants and that another 25% could result from a
combination of environmental and genetic factors (2). As the environment evolves, it is
necessary to respond to these new toxicological insults; however, new metrologies are
only now being developed to keep pace with this evolution of environment and health
related repercussions.
This dissertation is a study of both the toxicants and the immune system
components. It is both the development of metrology and its application to children’s
neurological health. We will begin in this introductory chapter by discussing a specific
area of environmental concern (mercury) and progress to the immune system and the
human response. In subsequent chapters, research pertaining to the metrology enabling
the assessment of both will also be discussed.

x

I. The Toxicant and Species of Mercury
Mercury is a ubiquitous element in the environment which has been
known for centuries. It was called “quicksilver” by Aristotle (3), and historical evidence
suggests that it was used for gold extraction as far back as about 290 A.D. (4). The
uptake, distribution, and excretion pathway of mercury in the body depends on its species
(3). Elemental mercury (HgO), which can enter the atmosphere from the activity of
volcanoes and from coal fired power plants (5), can come into the body through
inhalation and penetrate the blood-brain barrier, with the main non-occupational exposure
of it coming from dental amalgams (5). Inorganic mercury (Hg 2+) primarily targets the
kidney, from which it can be eliminated through the urine (5). Sources of Hg2+ include
cosmetic creams and batteries (5). Methylmercury (CH3Hg+) is a neurotoxin (6), and the
main source of human exposure to it comes from the consumption of fish (7). Tables 1 - 3
are taken from the FDA website and show the mercury levels in various types of fish (8).
It should be noted that the legal limit for mercury in commercial fish in the United States
is 1 ppm (9). For pregnant mothers, nursing mothers, women of childbearing age, and
small children, the FDA recommends avoiding fish that is high in mercury, such as
swordfish, and limiting intake of low mercury fish, such as salmon, to 12 ounces per
week (10).
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Another form of mercury, ethylmercury (C2H5Hg+), is a metabolic product of
Thimerosal, a preservative that was commonly used in childhood vaccines and is still
used in the influenza vaccine (11). The structure of Thimerosal is shown in Figure 1:

Figure 1 – Thimerosal structure

xiv

There has been much controversy over the years regarding the possible link between
autism and the usage of Thimerosal in vaccines. Recent large scale studies seem to
suggest the absence of such a link, although some have speculated that certain autistic
children may have greater genetic susceptibility to mercury toxicity, which could in turn
activate latent autism upon exposure (12).
So far in this introduction, several species of mercury have been described. One
of the biomolecules involved in the body’s defense against mercury species and other
toxicants is glutathione. This important biomolecule is described in the next section.

II. Species of Glutathione
Glutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine
and is synthesized in every cell the body (13). The structure of GSH is shown in Figure 2:
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Figure 2 – GSH

It is involved in several important functions, such as antioxidant activity and xenobiotic
detoxification (14). The key functional role is played by the cysteine thiol group, which is
involved in conjugation and reduction reactions (15). Cysteine (the rate limiting amino
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acid for GSH synthesis), can be synthesized by the body through a series of steps from
methionine, but according to Dr. S. Jill James, et al., this pathway appears to function
poorly in autistic children, thereby effectively rendering cysteine an essential amino acid
for them (16). The James research group has also analyzed GSH, glutathione disulfide
(GSSG – disulfide dimer formed from two GSH molecules, shown in Figure 3), and total
GSH (tGSH) in plasma samples from autistic children and healthy controls and found
that autistic children have lower plasma tGSH levels as well as lower plasma GSH/GSSG
ratios (often used as an indication of oxidative stress level) compared to the healthy
controls (13).
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Figure 3 – GSSG
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Strategies that are used to boost GSH levels include the consumption of protein
foods with cysteine (17) and the intake of supplements which function as cysteine
precursors, such as N-acetylcysteine (NAC), the structure of which is shown in Figure 4
(18).
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Figure 4 – N-acetylcysteine (NAC)

III. Mercury – GSH Conjugates
As mentioned earlier, glutathione plays an important role in the detoxification of
xenobiotics. For example, Hg2+ can bind to two GSH molecules as indicated in Figure 5,
at which point it is either eliminated in the urine in that form or further metabolized and
then eliminated in the urine (21).
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Figure 5 – Hg2+ conjugated with two GSH molecules
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With respect to CH3Hg+, evidence suggests that an important step in its detoxification is
the secretion of a CH3Hg+ - GSH conjugate, shown in Figure 6, from liver cells into bile
(20).
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Figure 6 – CH3Hg+ conjugated with GSH

In the body, the CH3Hg+ - GSH conjugate can be converted to a CH3Hg+ - cysteine
conjugate, which structurally resembles the amino acid methionine (20), and evidence
suggests that it is this resemblance which enables the CH3Hg+ - cysteine conjugate to
penetrate the blood-brain barrier (21). As shown in Figure 7 below, in a pregnant woman,
some of the CH3Hg+ taken in through the diet can get converted to Hg2+ and eliminated in
the feces, some can enter the brain, some can be eliminated through hair, and some make
it past the placenta into the unborn child (20). It can also enter the kidney, liver, cardiac
muscle, and skeletal muscle as well (21), and in blood, most of the CH3Hg+ is
concentrated in the red blood cells, rather than the plasma (20).
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Figure 7 – Fates of CH3Hg+ in a woman who is pregnant (21)

A study by Adams et al. in which GSH in red blood cells and heavy metals in urine from
autistic children were analyzed before and after chelation therapy suggested that exposure
to toxic metals other than mercury, such as lead, aluminum, cadmium, and antimony
results in higher than normal GSH levels due to the body’s increased GSH synthesis in
response to exposure to those metals, while exposure to mercury results in lower than
normal GSH levels, possibly due to the inhibition of GSH synthesis by the mercury (22).
The study also suggested that, as the body burden of toxic metals is lowered, the
concentration of GSH in red blood cells normalizes (22). Additionally, a separate study
by James et al. showed that depleted levels of GSH in neuroblastoma and glioblastoma
cells resulted from the exposure of those cells to Thimerosal (23), the preservative with
the C2H5Hg+ group mentioned the first part of this introduction which some have
suggested might play a role in the onset of autism in a vulnerable genetic subset of the
population.
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IV. Metallothionein and GSH
Studies also show that there is a synergistic relationship between GSH and
Metallothionein (MT), a cysteine rich protein which stores zinc and is also involved in
heavy metal detoxification. Specifically, GSH inhibits the release of zinc from MT while
GSSG activates it, and the greater the level of oxidative stress, the greater the amount of
zinc that is released from MT in response, which may be due to the need for zinc as part
of an antioxidant defense mechanism (24). This relationship is illustrated in Figure 8,
which was modified from Kang, Y. (24) by Hemasudha Chatragadda, a graduate student
in the Kingston Research group at Duquesne University, in collaboration with Dr. Martha
Herbert from Harvard University.

Figure 8 – Relationship between MT and GSH, modified from Kank, et al. (24)
by Hemasudha Chatragadda, a graduate student in the Kingston Research group at
Duquesne University
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V. Goals of the Research Projects Described in this Dissertation

According to the Center for Disease Control, on average, 1 in 110 children in the
United States has an autism spectrum disorder (ASD) (25). The prevalence is even higher
in other countries, such as South Korea, where about 1 in 38 children has an ASD (26).
With the high prevalence of autism in several locations, a significant amount of research
is being conducted to try to determine what is causing such a high prevalence, as well as
how to detect autism early in life, as evidence suggests that early intervention can have a
positive impact on these autistic children (27). The discovery and use of autism
biomarkers may enable medical professionals to make an early diagnosis of autism so
that they can implement early intervention strategies. One of the goals of the research
described in this dissertation is to follow up on the work of Dr. S. Jill James and others
with respect to the potential use of GSH as a biomarker for autism.
Another goal of the research described in this dissertation is to improve upon
already existing technology for the speciation of mercury in biological matrices such as
hair and blood. This can help with clinical evaluation of one’s level of mercury toxicity,
as some forms of mercury are more toxic than others.
An additional goal of the research described in this dissertation is to improve
upon existing technology for the evaluation of enzyme activity. The successful
achievement of this goal can also have applications in the diagnosis and treatment of
diseases.
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The research undertaken to achieve all of these goals involved the implementation
of advanced methodology using special sample preparation techniques along with mass
spectrometry. This advanced methodology is described chapter 1.
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Chapter 1

Metrology: Overview of Isotope Dilution Mass Spectrometry (IDMS) and
Speciated Isotope Dilution Mass Spectrometry (SIDMS)

Metrology is the study of measurement. The International Union of Pure
and Applied Chemistry (IUPAC) recognizes only four fundamental measurement types
that are definitive. Definitive by definition means that all the biases and errors can be
accessed, measured and known and corrected for to achieve a reliable and bias free
measurement possessing known accuracy and precision. Over the past 60 years the
science and art of Isotope Dilution Mass Spectrometry (IDMS), has evolved and
developed. IDMS, which involves spiking a given sample with a known concentration
and amount of a stable isotopically enriched form of the analyte of interest, equilibrating
the elemental or molecular forms so that both spike and natural are in exactly the same
species form, then performing a mass spectrometry measurement on the equilibrated
sample, and determining the concentration of the analyte based upon peak ratios, was
originally developed during the 1950s for elemental analysis (1). Frequently in IDMS, the
analyte species are converted to one form so that there is only one species for both the
natural and the spike analyte. Over the years, the usage of enriched isotopes for
quantitative mass spectrometry analysis has been applied to fields such as environmental
chemistry (2), clinical chemistry, pharmacokinetics, and toxicology (3). An equation for
IDMS is shown in Figure 1 solved for the concentration of the analyte (4):

1

Figure 1 – IDMS equation
Where:


Ax = abundance of isotope A in the natural abundant analyte in the sample



Bx = abundance of isotope B in the natural abundant analyte in the sample



As = abundance of isotope A in the enriched analyte in the spike



Bs = abundance of isotope B in the enriched analyte in the spike



Cx = concentration of the natural abundant analyte in the sample, which is what
the equation is solving for



Cs = concentration of enriched analyte in the spike in µmol/g



Wx = weight of the sample



Ws = weight of the spike



Rm = measured ratio of isotope A to isotope B (obtained from the mass
spectrometry measurements)

An example of an IDMS calculation with tGSH is shown next:

2

Application of IDMS to GSH
When GSH is analyzed by tandem electrospray mass spectrometry (ESI-MS-MS),
the collision energy can be adjusted such that the cysteinylglycine product ion (resulting
from the loss of pyroglutamate – 129 g/mol) is obtained and is the most abundant product
ion (5), as shown below in Figure 2:

Figure 2 – Fragmentation of GSH in the collision cell resulting in the formation of the
cysteinylglycine product ion of interest (in the green box)

Natural abundant GSH (307 g/mol):
-

Most abundant isotope detected at 308 m/z in positive mode ESI-MS

-

Main product ion (depending on collision energy) detected at 179 m/z in
MS/MS mode (loss of pyroglutamate)

Enriched GSH - has two 13C’s and one 15N on the glycine (310 g/mol)
-

Most abundant isotope detected at 311 m/z in positive mode ESI-MS

-

Main product ion (depending on collision energy) detected at 182 m/z in
MS/MS mode (loss of pyroglutamate)

3

IDMS calculation of tGSH concentration:

-

Ax = abundance of 182 m/z product ion in the natural abundant analyte in the
sample (0.00341)

-

Bx = abundance of 179 m/z product ion in the natural abundant analyte in the
sample (0.881)

-

As = abundance of 182 m/z product ion in the enriched analyte in the spike
(0.881)

-

Bs = abundance of 179 product ion in the enriched analyte in the spike
(0.00224)

-

Cx = concentration of GSH in the sample (unknown)

-

Cs = concentration of enriched GSH in the spike in µmol/g (2.09)

-

Wx = weight of the sample (0.247 g)

-

Ws = weight of the spike (0.251 g)

-

Rm = measured ratio of 182 m/z product ion to 179 product ion (obtained from
the mass spectrometry measurements) (1.21)

-

Cx = [((2.09 µmol/g)(0.251g))/(0.247g)] x [((0.881) – (1.21 x 0.00224))/((1.21
x 0.881) – 0.00341)] = 1.76 µmol/g

-

Molecular weight of GSH = 307 µg/µmol

-

Cx in µg/g (or ppm) = (1.76 µmol/g)(307 µg/µmol) = 540 ppm

Speciated Isotope Dilution Mass Spectrometry (SIDMS) entails spiking a sample
with known amounts of stable isotopically enriched analyte species, achieving

4

equilibration of spike and analyte species, performing mass spectrometry on the
equilibrated sample, and determining concentrations based upon ratios and the extent of
interconversion between or among species (4). This method, which was patented by H.M.
Skip Kingston, represented an advancement beyond traditional IDMS by correcting for
species interconversions that occurred during sample preparation and/or measurement
(6). These two methods (IDMS and SIDMS) constitute EPA Method 6800A (4).
Examples of SIDMS equations will be presented later in this section.
EPA Method 6800 A does not use traditional calibration curves and has several
advantages over the more traditional calibration curve method of analysis. Among them
include the absence of several sources of error common to the calibration curve method,
as illustrated in Figure 3 below:
Sources of Errors in Mass Spectrometric Analysis
• Stability of analyte in solution
• Accuracy in sample preparation
• Purity of calibration standards
• Choice of internal standard

Calibration Curve

• Improper instrumental setup
• Total dissolved solids

(not a definitive method)

• Non-spectral interferences

• More instrument time

• Matrix matching
• Standard addition

• More analyst time

• Sample introduction

• More reagents and chemicals

• Calibration curve inaccuracies

• More overall expense

• Chromatographic separation
• Instrument drift with time
• Nebulization efficiency
• Droplet size
• Physical properties of solution
• Acid content in the solution

Isotope Dilution and
Speciated Isotope Dilution

• Analyst’s lack of knowledge/training
• Background correction

(definitive method)
• Mass bias

• Direct mathematical solution

• Dead time

based on traditional and new
mathematical algorithms

• Interferences-Isobaric & polyatomic
• Signal suppression of the isotope in
excess over the one that is limited

Figure 3 Comparing error sources from calibration curve analysis vs EPA Method 6800A

As can be seen in Figure 3, the number of error sources from the usage of EPA 6800A is
significantly less than that from the usage of calibration curves. Only mass bias, dead
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time correction, isobaric interferences, and possible signal suppression of the excess
isotope over the limited isotope remain for the former method.
EPA Method 6800A also represents an improvement over the more common
internal standard method, which involves spiking the sample with a known amount of an
element or a molecular compound (depending on the application), performing mass
spectrometry on the sufficiently prepared sample (in its mass spectrometry application),
and calculating the concentration of the analyte based upon the intensity of the analyte
signal relative to the intensity of the internal standard signal (similar to, but not exactly
the same as, the method which utilizes the equation in figure 1). Both methods have the
advantage over the calibration curve method of enabling the analyst to correct for
fluctuations in signal intensity and for reductions in sample recovery; however, if one is
attempting to measure two or more species of an element or a molecular compound, and
there are interconversions between or among the species of interest, SIDMS can correct
for these interconversions.
SIDMS is particularly suited for the measurement of two species in which one can
convert to the other, such as the related species pair of GSH and GSSG. One of the more
common analyses that has given researchers difficulty with respect to conversion of one
species to another over the years has been that of GSH and GSSG, a particularly
important analysis from which one can obtain the GSH/GSSG ratio. As mentioned in the
introduction, this ratio is often used as an indicator of oxidative stress and has been
shown to be lower in plasma samples from autistic children than in ones from healthy
controls (7).
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To elaborate on the challenges with GSH and GSSG analysis, a potential
difficulty that researchers have had has been the conversion of the former to the latter
during sample preparation (8). A reagent often used to prevent this conversion is NEthylmaleimide (abbreviated NEM) (9), which blocks the thiol group on the GSH as
shown below in Figure 4:

Figure 4 – GSH NEM reaction

An additional characteristic of NEM is that it inhibits Glutathione reductase (GR), an
enzyme which converts GSSG back to GSH (8). SIDMS can complement the usage of
NEM by correcting for imperfections in its usage, such as the possible conversion of
7

GSH to GSSG before the NEM had a chance to react fully and the reduction in recovery
of GSSG, which can result from the reaction of NEM with its amines (7).
In describing the SIDMS equations for GSH and GSSG analysis that are designed
to correct for conversion of GSH to GSSG, it is best to start off with a simple analogy. If
one has several slices of wheat bread and several slices of white bread, one can make
three types of sandwiches: ones with two slices of wheat bread, ones each with a slice of
wheat bread and a slice of white bread (“hybrid” sandwiches), and ones with two slices of
white bread. In a similar manner, if natural abundant GSH (307 g/mol) and isotopically
enriched GSH with two 13C’s and one 15N (310 g/mol) are equilibrated and oxidation
occurs, one can end up with three types of oxidized GSSG: natural abundant GSSG (612
g/mol) from two molecules of natural abundant GSH (analogous to wheat bread
sandwiches), partially enriched GSSG (615 g/mol) with two 13C’s and one 15N from the
combination of one natural abundant GSH molecule and one isotopically enriched GSH
molecule (analogous to the “hybrid” sandwiches), and GSSG with four 13C’s and two
15

N’s (618 g/mol) from two molecules of enriched GSH (analogous to the white bread

sandwiches). One can determine how much of the GSH converted to GSSG by spiking
the sample with enriched GSSG in which the enrichment is different from the enriched
GSSG that comes from oxidation (such as GSSG that has four 13C’s (616 g/mol).
Suppose one has 1 mole of wheat bread slices (6.02 x 1023 slices), referred to as
“n” and the same number of white bread slices, referred to as “m,” that gets converted to
sandwiches. Mathematical relationships pertaining to the number of each kind of
sandwich formed, which were worked out by Dr. John Kern from the Mathematics
department at Duquesne University (10), are described on the following pages.
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φ = # of ways to select k items from w = w!/[k! (w-k)!]
e.g. if w=9 and k=2,
φ = (9 x 8 x 7 x 6 x 5 x 4 x 3 x 2 x 1)/(2!)(7 x 6 x 5 x 4 x 3 x 2 x 1) = (9 x 8)/2 = 36
If w is an extremely large number (such as 6.02 x 1023) and k = 2, for all practical
purposes, φ = w2/2
The total number of sandwich combinations = [(n + m)!]/ k! ((n + m)-k)!]
= [(6.02 x 1023 + 6.02 x 1023 )(6.02 x 1023 + 6.02 x 1023 – 1)]/2
= [(12.04 x 1023)(12.04 x 1023 – 1)]/2
(neglect -1) = (12.04 x 1023)2/2 = 7.25 x 1047 sandwiches
= (n + m)2/2
The probability (expressed as a decimal) of getting a wheat bread sandwich
= [(n2)/2]/[(n + m)2/2]
= [(6.02 x 1023)2/2]/[(12.04 x 1023)2/2]
= (6.02 x 1023)2/ (12.04 x 1023)2 = 0.250
The probability (expressed as a decimal) of getting a white bread sandwich
= [(m2)/2]/[(n + m)2/2]
= [(6.02 x 1023)2/2]/[(12.04 x 1023)2/2]
= (6.02 x 1023)2/ (12.04 x 1023)2 = 0.250
The probability (expressed as a decimal) of getting a sandwich with one slice of wheat
bread and one slice of white bread = (n x m)/[(n + m) 2/2]
= 2mn/(n + m)2
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= [(2)(6.02x1023)(6.02x1023)]/ (6.02x1023 + 6.02x1023)2
= 0.500
The same 0.500 answer can be obtained by using units of moles instead
= [(2)(1mole)(1mole)]/(1mole+1mole) 2
= 0.500
These mathematical relationships can be applied to GSH and GSSG analysis. Let
“n” = the µmol of natural abundant 307 g/mol GSH that became oxidized either to natural
abundant 612 g/mol GSSG or “hybrid” 615 g/mol GSSG. Let “m” = the µmol of
isotopically enriched 310 g/mol GSH that became oxidized to either “hybrid” 615 g/mol
GSSG or fully enriched 618 g/mol GSSG. The ratio of the probability of getting “hybrid”
615 g/mol GSSG (sandwich with one slice of wheat bread and one slice of white bread)
to the probability of getting fully enriched 618 g/mol GSSG (sandwich with two slices of
white bread) equals the ratio of the peak areas from LC/MS/MS analysis of the peaks in
the chromatogram representing those species of GSSG (after taking into account the
abundances of those isotopes and subtracting out the contribution coming from natural
abundant GSSG).
In positive mode ESI-MS, the most abundant isotope from natural abundant 612
g/mol GSSG is detected at 613 m/z, that from “hybrid” 615 g/mol GSSG with two 13C’s
and one 15N is detected at 616 m/z, that from enriched 616 g/mol GSSG with four 13C’s is
detected at 617 m/z, and that from enriched 618 g/mol GSSG with four 13C’s and two
15

N’s (which came from two 310 g/mol GSH’s that each had two 13C’s and one 15N) is

detected at 619 m/z. In positive mode electrospray tandem mass spectrometry (ESIMS/MS) with the collision energy adjusted so as to make the most abundant product ion
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that which results from the loss of two pyroglutamates from GSSG (loss of 258 g/mol),
the numbers above change to 355 m/z, 358 m/z, 359 m/z, and 361 m/z, respectively. The
mathematical relationship described on the next two pages can be used to determine GSH
and GSSG concentrations.

(358 m/z peak area)/(361 m/z peak area)
= (probability of getting “hybrid” 615 g/mol GSSG)/(that of getting 618 g/mol GSSG)
= [(2mn)/(n+m)2]/[(m2)/(m+n)2]
= 2n/m
m = µmol of 310 g/mol GSH that became oxidized
= (2 x µmol of 618 g/mol GSSG present) + (µmol of 615 g/mol GSSG present)

The mass of the solution of the enriched 310 g/mol GSH that was added is known,
as is the mass and concentration of the enriched 616 g/mol GSSG solution. One can
determine the concentration (and, thus, µmol) of the 618 g/mol GSSG and 615 g/mol
GSSG present by performing IDMS on both with the 616 g/mol GSSG representing the
enriched analyte. One µmol of 618 g/mol GSSG comes from two µmols of 310 g/mol
GSH, and one µmol of 615 g/mol GSSG comes from one µmol each of 307 g/mol GSH
and 310 g/mol GSH. Using this relationship, one can determine “m” (the µmol of 310
g/mol GSH that became oxidized). Once “m” is known, one can determine “n” (the µmol
of natural abundant 307 g/mol GSH that converted to either 612 g/mol GSSG or 615
g/mol GSSG) using the following relationship
[(358 m/z peak area)/((361 m/z peak area)*(2))]*m
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=n
= µmol of 307 g/mol GSH that became oxidized
Since the mass of the sample (e.g. blood sample, plasma sample, etc.) is known, one can
determine the concentration of GSH that became oxidized to GSSG in units of µmol /g
(and, subsequently, µg/g) and perform the necessary subtraction from the uncorrected
GSSG concentration and the necessary addition to the uncorrected GSH concentration.
Another area in which SIDMS can be applied is mercury speciation. As
mentioned in the introduction, different species of mercury have different levels of
toxicity and different target organs, hence the need for the analysis of the individual
mercury species, rather than just total mercury, in order to determine one’s level of toxic
exposure. Dr. G.M. Mizanur Rahman from Duquesne University described in his
doctoral dissertation from 2004 the SIDMS equations that can be used for Hg 2+ and
CH3Hg+ speciation, which are shown below and on the next pages (11):
For Hg+
= [(199Ax
(199Ax

Wx + 199

CH 3 Hg+

Wx + 199

[(202Ax

CH 3 Hg+

Wx + 202

CH 3 Hg+

)β]/

CH 3 Hg+

Wx + 201

CH 3 Hg+

Wx + 201

CH 3 Hg+

)β]

) (1 – α) +
CH 3 Hg+

CH 3 Hg+

Wx + 202
(202Ax

CH 3 Hg+

) (1 – α) +

CH 3 Hg+

= [(201Ax

[(202Ax

CH 3 Hg+

Wx + 202
(202Ax

(201Ax

) (1 – α) +

CH 3 Hg+

)β]/

) (1 – α) +

CH 3 Hg+

Wx + 202

CH 3 Hg+
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CH 3 Hg+

CH 3 Hg+

)β]

For CH3Hg+
CH3Hg+

= [(199Ax

(199Ax

Wx + 199

CH 3 Hg+

Wx + 199

[(202Ax

[(202Ax

CH 3 Hg+

) (1 – β)]/

)α +

CH 3 Hg+

Wx + 202

= [(201Ax

(201Ax

CH 3 Hg+

Wx + 202
(202Ax

CH3Hg+

CH 3 Hg+

)α +

CH 3 Hg+

CH 3 Hg+

Wx + 201

CH 3 Hg+

Wx + 201

CH 3 Hg+

) (1 – β)]

)α +
CH 3 Hg+

Wx + 202
(202Ax

CH 3 Hg+

CH 3 Hg+

) (1 – β)]/

)α +

CH 3 Hg+

Wx + 202

CH 3 Hg+

CH 3 Hg+

CH 3 Hg+

) (1- β)]

Where,
is the isotope ratio of 199Hg to 202Hg of Hg2+ in the spiked sample (unknown)
is the isotope ratio of 201Hg to 202Hg of Hg2+ in the spiked sample (unknown)
CH3Hg+

is the isotope ratio of 199Hg to 202Hg of CH3Hg+ in the spiked sample

(unknown)
CH3Hg+

is the isotope ratio of 201Hg to 202Hg of CH3Hg+ in the spiked sample

(unknown)
199

Ax is the relative isotope abundance of 199Hg in the sample

202

Ax is the relative isotope abundance of 202Hg in the sample

201

Ax is the relative isotope abundance of 201Hg in the sample

199

is the relative isotope abundance of 199Hg in the 199Hg2+ spike

202

is the relative isotope abundance of 202Hg in the 199Hg2+ spike

201

is the relative isotope abundance of 201Hg in the 199Hg2+ spike
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199

CH 3 Hg+

is the relative isotope abundance of 199Hg in the CH3201Hg+ spike

202

CH 3 Hg+

is the relative isotope abundance of 202Hg in the CH3201Hg+ spike

201

CH 3 Hg+

is the relative isotope abundance of 201Hg in the CH3201Hg+ spike

is the concentration of Hg2+ in the sample (µmol/g, unknown)
CH 3 Hg+

is the concentration of CH3Hg+ in the sample (µmol/g, unknown)

Wx is the weight of the sample (g)
is the concentration of Hg2+ in the 199Hg2+ spike (µmol/g)
is the weight of the 199Hg2+ spike (g)
CH 3 Hg+
CH 3 Hg+

is the concentration of CH3Hg+ in the CH3 201Hg+ spike (µmol/g)
is the weight of the CH3 201Hg+ spike (g)

α is the proportion of Hg2+ transformed to CH3Hg+ (unknown)
β is the proportion of CH3Hg+ transformed to Hg2+ (unknown)

In more recent years, our laboratory has used CH3200Hg+ in place of CH3201Hg+, in part
because the 201Hg isotope is now used for enriched C2H5Hg+ (C2H5 201Hg+) so as to
enable one to perform SIDMS with three Hg species (Hg2+, CH3Hg+, and C2H5Hg+ )
using SIDMS equations for three-species analysis that were also described in Dr.
Rahman’s dissertation (11). It was considered important to add C2H5Hg+ to the number of
mercury species analyzed is because, as mentioned in the introduction, it is a metabolic
product of Thimerosal, a preservative still used in some vaccines, such as the influenza
vaccine (12).
In summation, the speciation of glutathione and mercury is of critical
toxicological importance and can be achieved without calibration curves by using EPA
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Method 6800A. The following chapters will describe these applications and
developments for these specific analyses.
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Chapter 2 – Development and Refinements of Application of IDMS and SIDMS to
Mercury Speciation in Specific Matrices

2 A. Mercury Speciation in Hair
As mentioned in the introduction, one of the fates of CH3Hg+ in the body is
elimination through the hair (1). A normal concentration of hair mercury is between 0.4
and 6 ppm (2), with most (over 90%) of the mercury consisting of CH3Hg+ (3).
According to the EPA, a toxic threshold for hair mercury is 10 ppm (4). Evidence
indicates hair mercury concentration increases with increasing fish consumption (5).
During the sample preparation and analysis of samples with both CH3Hg+and
Hg2+, methylation of inorganic mercury and demethylation of CH3Hg+ occur. IDMS is
capable of analyzing total mercury but it is not capable of correcting for these
interconversions of the two related species of mercury. For these corrections, SIDMS, in
its most applicable form as described in EPA method 6800A, must be applied. In the
application of 6800A, there are optimizations that can be applied, and these are part of
the scientific contribution demonstrated in this chapter.
In addition to CH3Hg+and Hg2+, C2H5Hg+, which is a metabolic product of
Thimerosal, has also been detected in human hair (6,7), as well as blood (7) from persons
exposed to Thimerosal. Studies from mice and rats suggest that C2H5Hg+from Thimarosal
can be converted to Hg2+ in mammals (8,9), and a study of infants exposed to
Thimerosol suggests that mercury from the Thimerosal exposure can be eliminated
through the stools (10). More research needs to be undertaken to determine the fates of
C2H5Hg+ in the body.
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To illustrate the importance of accounting for possible species interconversion, as
well as the importance of taking into consideration percent recovery of the analytes of
interest, a set of experiments was completed in our laboratory in which several literature
hair sample preparation protocols were assessed by traditional external calibration. This
set of experiments is described in the next section.

2A i. Analysis of Mercury Species in hair using published sample preparation
protocols with traditional external calibration

Materials and Methods
Reagents/standards:
The hair standard used was a certified reference material (IAEA – 085) from the
International Atomic Energy Agency (Vienna, Austria) that was certified for total
mercury and methylmercury. The water used for solutions was double deionized (DDI)
water from a Barnstead NANOpure Ultrapure Water System (Dubuque, IA). Reagent
grade nitric acid, hydrochloric acid, hydrogen peroxide, L-cysteine, and ethanol were
obtained from Fisher Scientific (Pittsburgh, PA). Both nitric acid and hydrochloric acid
were purified using sub-boiling distillation in a quartz still (Milestone, Monroe, CT).

Instrumentation/analytical methods:
For analysis of the prepared samples, liquid chromatography-inductively coupled
plasma-MS (LC-ICP-MS) analysis was performed using isocratic elution with a Waters
(Milford, MA) Novapak C18 reversed phase column (150 x 3.9 mm, 4 µm) and a 709 IC
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polymeric inert pump with an 838 advanced sample processor for automatic sample
delivery from Metrohm Peak (Houston, TX) coupled to an Agilent 4500 ICP-MS
(Agilent Technologies, Palo Alto, CA). The mobile phase consisted of 0.4% cysteine, pH
5. The flow rate was 1.0 ml/min, and the injection volume was 100 µl. The
chromatography and automation equipment were situated in a high efficiency particulate
air (HEPA) filter class 100 clean hood chamber next to the ICP-MS in a class 1000 clean
room laboratory. For data evaluation using external calibration, quantification was based
on chromatographic peak area by monitoring the signal for the 202Hg isotope. For each
sample preparation method, four sample preparation replicates and four analysis
replicates were completed (n=16).

Sample preparation methods used from the literature (note –four sub samples of the
mercury hair samples were prepared in each case, procedural blanks were prepared
with the samples for quality assurance purposes):

Method 1 (from reference 11)
For acid leaching with 2 M HCl, four 50 mg sub-samples of the hair reference
material were each placed into a 15-mL disposable glass centrifuge tube with a snap-on
cap, to which two drops of ethanol and 5 ml of 2 M HCl were added. A small amount of
mercury-free cotton was added to prevent the hair from floating. Each centrifuge tube
was tightly capped and heated at 100oC in a water bath for 5 minutes. After cooling, the
sample solutions were then stirred well using a vortex mixer and centrifuged for 5
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minutes at 3200 rpm to separate the hair. Each cooled extract was transferred to a tarred
50-mL polypropylene centrifuge tube and diluted to 20 mL by adding DDI water.

Method 2 (from reference 12)
For acid leaching with 2 M HCl, four 100 mg portions of hair sample were placed
into 15 mL disposable glass centrifuge tubes with a snap on caps, to which 2 ml of 2M
HCl were added. The centrifuge tubes were tightly capped and heated at 100 oC in a
water bath for 15 minutes. The sample solutions were then centrifuged for 5 minutes at
3200 rpm to separate the hair. The cooled extracts were transferred into tarred 50 ml
polypropylene graduated centrifuge tubes and diluted to 20 mL by adding DDI water.

Method 3 (from reference 13)
For acid leaching with 4% (v/v) HCl, a 3 ml portion of 4% (v/v) HCl was shaken
on a mechanical shaker with 200 mg of hair for 2 minutes. The hair was then separated
by centrifugation at 2700 rpm for 20 minutes. The supernatant containing the
methylmercury was transferred into a tarred 50 mL polypropylene graduated centrifuge
tube. The process was repeated with 2 ml of 4% (v/v) hydrochloric acid, and the
combined supernatants were diluted to 20 mL with DDI water. Four sample replicates
were prepared.

Method 4 (from reference 14)
For acid leaching with 2 M HCl, approximately 100 mg of hair sample was put
into a 50 mL polypropylene graduated centrifuge tube, and 5 mL of 2 M HCl were added.
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The tubes were closed and shaken on a mechanical shaker for 4 hours. The tubes were
then centrifuged at 2500 rpm for 20 minutes to separate the hair. The supernatant
containing the methylmercury was transferred into a tarred 50 mL polypropylene
centrifuge tube and diluted with DDI water to 20 mL. Four sample preparation replicates
were prepared.

Method 5 (from reference 15)
For cold acid digestion with 2 M HCl, to prepare four sample preparation
replicates, approximately 200 mg of hair sample were weighed into four 50 ml
polyproppylene graduated centrifuge tubes, and 5 mL of 2 M HCl were added to each
tube. The tubes were closed and kept on the bench top for 24 hours. These tubes were
then centrifuged at 2500 rpm for 20 minutes to separate the hair. The supernatants
containing the methylmercury were transferred into tarred 50 mL polypropylene
graduated centrifuge tubes and diluted with DDI water to 20 mL.

Method 6 (from reference 16)
For acid leaching with 5 M HNO3, approximately 50 mg of hair sample was
placed into a 15 mL disposable glass centrifuge tube with a snap on cap, to which 350 µL
of 5 M HNO3 were added. The centrifuge tube was loosely capped and heated at 100 oC in
a water bath for 120 minutes. The sample solution was then stirred well using a vortex
mixer and then centrifuged for 5 minutes at 3200 rpm. The cooled extract was transferred
into a tarred 50 ml polypropylene centrifuge tube and diluted to 20 mL by adding DDI
water. Four sample preparation replicates were completed.
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Method 7 (from reference 17)
For cold acid digestion with concentrated HNO3 and 30% H2O2, approximately
100 mg portions of the sample were weighed into four 15 ml centrifuge tubes; 2 mL of
concentrated HNO3 and 1 ml of 30% H2O2 were added to each tube. The mixtures were
then vortexed and kept on the bench top overnight. The next day, the mixtures were
vortexed for 1 minute and then centrifuged for 5 minutes at 3500 rpm. The extracts were
transferred into 50 ml polypropylene sample vials and diluted with DDI water to 20 ml.

Results and Discussion
The certified value for total mercury in hair standard IAEA-085 is 23.2 ± 0.8
ppm, and that for methylmercury is 22.9 ± 1.0 ppm. Table 1 shows the results obtained
using the seven sample preparation methods described above from the literature and
traditional external calibration with LC-ICP-MS. Concentrations are given in ppm, and
results are reported at the 95 % C.I. The percent recoveries are given in the parentheses.

Method

[Hg2+] in ppm
(as Hg)

[CH3Hg+ ] in ppm (as
Hg), percent
recoveries in
parentheses
22.9 ± 1.0

Sum of species (ppm), percent
recoveries in parentheses

23.2 ± 0.8
certified
value
0.63 ± 0.18
20.10 ± 0.26 (88 ± 1)
20.73 ± 0.32 (89 ± 1)
1
0.23 ± 0.02
19.88 ± 1.36 (87 ± 6)
20.11 ± 1.36 (87 ± 6)
2
not detected
20.36 ± 1.05 (89 ± 5)
20.36 ± 1.05 (88 ± 5)
3
0.27 ± 0.29
22.36 ± 0.86 (98 ± 4)
22.63 ± 0.91 (98 ± 4)
4
not detected
18.38 ± 0.93 (80 ± 4)
18.38 ± 0.93 (79 ± 4)
5
8.89 ± 0.69
12.83 ± 0.68 (56 ± 3)
21.72 ± 0.97 (94 ± 4)
6
23.57 ± 0.78
1.62 ± 0.15 (7± 1)
25.19 ± 0.79 (109 ± 3)
7
Table 1 – results from mercury species analysis using literature methods
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As can be seen in Table 1, there appears to have been a significant amount of
conversion of CH3Hg+ to Hg2+ in methods 6 and 7, much more so than in the other five
methods. It is interesting to note that the latter two methods involved the usage of HNO 3
along with either an elevated temperature (100OC for 2 hours) or a relatively long
reaction time (overnight, ~ 16 hours), whereas the other five methods used HCl instead of
HNO3. It was also observed that, with the exception of method 4, the percent recovery of
CH3Hg+ was less than 100%. With respect to methods 1, 2, 3, and 5, this result was most
likely due to incomplete extraction of the CH3Hg+; for methods 6 and 7, this result was
likely due, as mentioned above, to the conversion of CH3Hg+ to Hg2+.
The results in table 1 clearly indicate the importance of accounting for both
species interconversion and sample recovery, as failure to do so would decrease the level
of confidence that one has in the final reported results. SIDMS is designed to address
both of these issues. In addition, for field applications, a sample preparation method
involving the equilibration of natural abundant and enriched analytes on a solid phase
extraction (SPE) column for the purpose of using SIDMS technology would be useful as
well so that, if unstable analytes partially decompose or interconvert with other analytes
before they reach the laboratory, EPA Method 6800A will correct for the transformations.
The next section describes experiments used to demonstrate these applications as they
pertain specifically to hair mercury speciation.

2 A ii – Analysis of Mercury Species in hair using SIDMS with iSPIKE Methodology
In his 2006 PhD dissertation, David Lineman described the procedure of loading
an SPE column with an isotopically enriched analyte and then loading that same column
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at some later time with the natural abundant analyte such that equilibration between the
former and latter analytes occurred on the column. At that time, only the GC-MS
application of this concept was implemented and described. It had been envisioned to
follow up on this concept with LC-MS or other types of mass spectrometry applications
to investigate the general application of this novel method of IDMS equilibration and
spiking. Following elution, mass spectrometry analysis of the eluent would enable one to
implement a new type of novel, complete IDMS analysis (18). This procedure is known
as the iSpike ® method (registered trademarked of Applied Isotope Technologies, AIT,
the “i” refers to “isotope”), and is especially applicable to field sample preparation. It also
has been envisioned for clinical and homeland defense applications and patent are
pending on these applications. To follow up on this work, an experiment was completed
involving the speciation of mercury in hair. In this experiment, an attempt to achieve
equilibration between the natural abundant and enriched mercury species on a specialized
SPE column was made, and the results using that sample preparation method were
compared to those from a method in which equilibration occurred in a microwave vessel.
This experiment is described below.

Materials and Methods
Reagents/standards:
The hair standard used was certified reference material (IAEA – 085) from the
International Atomic Energy Agency (Vienna, Austria) that was certified for total
mercury and CH3Hg+ . The water used for solutions was double deionized (DDI) water
from a Barnstead NANOpure Ultrapure Water System (Dubuque, IA). Reagent grade
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nitric acid and L-cysteine were obtained from Fisher Scientific (Pittsburgh, PA). Nitric
acid was purified using sub-boiling distillation in a quartz still (Milestone, Monroe, CT).
Isotopically enriched 199Hg2+ and CH3200Hg+ and sulfhydryl cotton fiber SPE were
obtained from Applied Isotope Technologies, Inc. (Pittsburgh, PA).

Instrumentation/analytical methods:
For microwave sample preparation, a Milestone (Monroe, CT) Ethos 1600
microwave system was used. This system was equipped with temperature feedback
control and magnetic stirring, as well as high pressure (maximum pressure – 100 bar)
closed vessel microwave vessels made of high purity TFM (a thermally resistant form of
fluoropolymer) with a capacity of 100 ml.
For analysis of the prepared samples, direct analysis of the SPE eluents were
made with an Agilent 4500 ICP-MS (Agilent Technologies, Palo Alto, CA).
Quantification was performed by monitoring the 199Hg, 200Hg, and 202Hg isotopes for both
the eluent with the Hg2+ and that with the CH3Hg+, and the equations described in chapter
1 were used for SIDMS analysis. For each sample preparation method, three sample
preparation replicates and four analysis replicates were completed (n=12). The isotope
ratios were corrected for dead time, and a solution with natural abundant Hg 2+ and
CH3Hg+ was also analyzed periodically between samples to obtain the mass bias
correction factor.
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Sample preparation Method A – equilibration of natural abundant and enriched
analytes in the microwave vessel
Procedures described in EPA Method 3200 (19) were used for this experiment. To
three microwave vessels were each added a stir bar, 100 mg of certified reference
material hair (IAEA-085), known amounts of 199Hg2+ and CH3200Hg+, and 10 ml of 4 M
HNO3. To a fourth vessel were added everything that was in the other three except the
hair standard in order to serve as a procedural blank. Microwave irradiation was applied
to the samples with stirring (2 minute ramp to 100OC, 10 minute hold at 100OC). After
cooling, each sample was filtered through a 0.22 µm glass filter. To each sample were
then added 2 mL of 0.2 M of pH 3.0 acetate buffer, followed by enough 10 N NaOH to
adjust the pH of the sample solution to ~ 3 – 4.
For SPE, four sulfhydryl cotton fiber SPE columns were conditioned with 10 mL
of H2O, then 10 mL of 6 N HCl, and lastly 15 mL of H2O. The pH adjusted samples were
applied to the columns, and 8 ml of a solution containing 1.0 M HCl and 1.0 M NaCl
were run through each column, followed by 2 mL of H2O. The eluents were collected and
referred to as “eluent 1a, 1b,” etc. Another 8 mL of a solution consisting of 6M HCl,
saturated NaCl, and 0.1% CuCl2·2H2O were applied to each column, followed by 2 mL
of H2O, and the eluents from the application of this solution was collected as well
(referred to as “eluent 2a, 2b,”etc.).
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Sample Preparation Method B – Equilibration of natural abundant and enriched
analytes on the SPE column
The samples were prepared exactly the way they were in method A except that no
199

Hg2+ and CH3200Hg+ were added to the microwave vessel; instead, they were added to

the conditioned SPE columns. After implementing the microwave protocol and adjusting
the pH of the samples to ~ 3 – 4 with the acetate buffer and the 10 N NaOH, the samples
were applied to the conditioned and double spiked columns, and the eluents were
collected just like in method A.

Results and Discussion
The CH3Hg+, which was less strongly adsorbed to the stationary phase than Hg 2+,
was detected in eluent 1, and the Hg2+, more strongly adsorbed to the stationary phase,
was detected in eluent 2. The reason for this difference in adsorption strength can be seen
in the schematic representation of the interaction between these analytes and the
stationary phase shown in Figures 1 and 2 below:

H3C

Hg

S

Figure 1 – Interaction between CH3Hg+ and the stationary phase – weaker adsorption due
to analyte bonding to only one Sulfur on the stationary phase

S

Hg

S

Figure 2 – Interaction between Hg2+ and the stationary phase – stronger adsorption due to
analyte bonding to two Sulfurs on the stationary phase
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The results from the analysis of the mercury speciation in hair using methods A
and B are shown in Table 2 (values reported at 95% C.I.):
Hg2+ concentration
in ppm

CH3Hg+
concentration in
ppm
22.9 ± 1.2
22.698 ± 0.990

Sum of Species in
ppm

23.2 ± 0.8
Certified value
1.617 ± 0.104
23.315 ± 0.995
Method A –
equilibration in the
microwave vessel
1.400 ± 0.092
22.766 ± 1.301
24.166 ± 1.304
Method B –
equilibration on
the SPE column
Table 2 – Mercury Speciation in hair using equilibration in the microwave vessel and
equilibration on the SPE column

The results from the mercury speciation in hair using methods A and B were
consistent with each other as well as with the certified values. These results demonstrate
the usefulness of SIDMS for mercury speciation as well as the fact that equilibration
between natural abundant and isotopically enriched mercury species can occur on the
SPE column. This equilibration enables one to obtain the correct concentration of the
analytes, even if the recovery is less that 100%. This is because the “apparent” recovery
remains the same (i.e. if the recovery of the natural abundant analyte is 80%, that of the
enriched analyte will also be 80%, so the ratio of the former to the latter will remain
constant). Later on in this chapter, an experiment mimicking a 25% reduction in
recovery of the analytes of interest will be described to demonstrate these concepts
further.
As mentioned earlier, a method capable of analyzing C2H5Hg+ in addition to Hg2+
and CH3Hg+ would be useful. In the next section is a description of an experiment in
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which these three mercury species are interconverting, and a set of equations based on
work done by Dr. Rahman, which are contained in his dissertation (20) and were referred
to in the previous chapter, were used to quantitatively successfully determine the
concentrations of the three mercury species. These equations are an extension of the two species
equations shown earlier, and are available in the literature from the Kingston Research Group in
several publications and presentations.

2 A iii – Analysis of three Mercury Species in Hair using SIDMS

As mentioned on p. 17, there is documented evidence of ethylmercury being
detected in hair (6,7) and blood (7). To expand upon this work which is already in the
literature, an experiment was carried out to demonstrate how SIDMS can correct for
interconversions among mercury species, such as C2H5Hg+, Hg2+ and CH3Hg+ during
sample preparation and/or analysis. This experiment is described next.

Materials and Methods
Reagents/standards:
The hair standard used was certified reference material (IAEA – 085) from the
International Atomic Energy Agency (Vienna, Austria) that was certified for total
mercury and CH3Hg+. The water used for solutions was double deionized (DDI) water
from a Barnstead NANOpure Ultrapure Water System (Dubuque, IA). Reagent grade
nitric acid and L-cysteine were obtained from Fisher Scientific (Pittsburgh, PA). Nitric
acid was purified using sub-boiling distillation in a quartz still (Milestone, Monroe, CT).
A solution of known concentration of C2H5Hg+ was supplied by Applied Isotope
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Technologies (Pittsburgh, PA). Isotopically enriched 199Hg2+,CH3200Hg+ and C2H5 201Hg+
were also supplied by Applied Isotope Technologies.

Instrumentation/analytical methods:
For microwave sample preparation, a Milestone (Monroe, CT) Ethos 1600
microwave system was used. This system was equipped with temperature feedback
control and magnetic stirring, as well as high pressure (maximum pressure – 100 bar)
closed vessel microwave vessels made of high purity TFM (a thermally resistant form of
fluoropolymer) with a capacity of 100 mL.
For analysis of the prepared samples, LC-ICP-MS analysis was performed using
isocratic elution with a Waters (Milford, MA) Novapak C18 reversed phase column (150
x 3.9 mm, 4 µm) and a 709 IC polymeric inert pump with an 838 advanced sample
processor for automatic sample delivery from Metrohm Peak (Houston, TX) coupled to
an Agilent 4500 ICP-MS (Agilent Technologies, Palo Alto, CA). The mobile phase
consisted of 0.2% cysteine. The flow rate was 1.0 mL/min, and the injection volume was
100 µl. The chromatography and automation equipment were situated in a high efficiency
particulate air (HEPA) filter class 100 clean hood chamber next to the ICP-MS in a class
1000 clean room laboratory. Quantification was performed by monitoring the 199Hg,
200

Hg, 201Hg and 202Hg isotopes for the Hg2+, CH3Hg+, and C2H5Hg+ peaks in the

chromatograms, and isotope ratios for SIDMS analysis were based upon peak area ratios.
Two sample preparation replicates and four analysis replicates were completed (n = 8).
The isotope ratios were corrected for dead time, and a solution with natural abundant
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Hg2+, CH3Hg+, and C2H5Hg+ was also analyzed periodically between samples to obtain
the mass bias correction factors.

Sample Preparation
To a microwave vessel were added a stir bar and 50 mg of IAEA-085 hair
standard, and this hair was spiked with a known amount of natural abundant
ethylmercury to mimic a hair sample with three mercury species instead of two. To the
vessel were then added known amounts of 199Hg2+, CH3200 Hg+, and C2H5201Hg+, along
with 10 mL of 4M HNO3. Microwave irradiation was implemented following the
protocol described in EPA Method 3200 (14) with a 2 minute ramp to 100 OC, followed
by a10 minute hold at 100OC. After filtration through a 0.22 µm filter, the sample was
analyzed by LC-ICP-MS as described above. Sample preparation was done in duplicate,
with 4 analysis replicates for each sample preparation replicate (n=8). Procedural blanks
that included everything except the certified hair standard and spiked natural abundant
C2H5Hg+ were prepared and analyzed in a likewise manner.
Results and Discussion
The results from the SIDMS analysis of the three mercury species in hair are
shown in Table 3 (results reported in units of ppm at 95% C.I.):
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Certified
Value
SIDMS
measured

Hg2+

CH3Hg+

C2H5Hg+

% conv.
of Hg2+
to
CH3Hg+

% conv.
of
CH3Hg+
to Hg2+

*

NA

1.30 ±
0.74

22.9 ±
1.4
22.06 ±
0.44

21.10 ±
1.0

8.29 ±
0.87

% conv.
of
C2H5Hg+
to
CH3Hg+
NA

% conv.
of
C2H5Hg+
to Hg2+

% conv.
of Hg2+
to
C2H5Hg+

NA

% conv.
of
CH3Hg+
to
C2H5Hg+
NA

NA

NA

5.36 ±
0.84

1.73 ±
0.33

6.78 ±
0.68

74.31 ±
4.03

1.21 ±
0.42

* Not present originally, spiked so as to obtain 22.7 ppm ± 1% RSD
Table 3 – Results - analysis of Hg2+, CH3Hg+, and C2H5 201Hg+ in spiked hair standard
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The expected values were obtained despite the interconversions among the
mercury species, particularly the conversion of C2 H5Hg+ to Hg2+ (over 70% conversion).
These results demonstrate the usefulness of the SIDMS method for correcting for species
interconversions so as to enable one to obtain the original analyte concentrations. In this
context, the specific application was for mercury speciation in hair. The method can also
be used for the determination of mercury species in other matrices as well, one of them
being blood. This application of SIDMS to mercury speciation in blood is described in
the next section.

2B – Mercury Speciation in blood
As in hair, normally, most of the mercury in blood is in the form of
methylmercury. The analysis of mercury species in blood is somewhat more challenging
than it is in hair, however, due to the lower concentration of mercury in blood, as
literature values for the hair to blood mercury ratio have been found to be between 140
and 370 (21). According to the EPA, blood mercury levels are commonly below a level
associated with possible health effects, 5.8 µg/ml (about 6 ppb) (22). Over the years,
methods for analyzing mercury species in blood have included isotope dilution with
alkaline digestion and sodium tetraethylborate derivatization combined with gas
chromatography/ICP/MS (GC/ICP/MS) analysis (23) as well as ultrasound extraction
combined with LC/ICP/MS analysis with quantification based on external calibration (9).
SIDMS can expand upon existing methods like these by taking into account both sample
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recovery and species interconversion. Experiments designed to demonstrate this concept
are described in the next section.

2B i – Analysis of Mercury Species in Blood with Elevated Mercury Concentration
Materials and Methods

Reagents/Standards
The human blood sample used was obtained from the Stanford University blood
bank and was screened for the absence of Hepatitis B and HIV before being sent to
Duquesne University. The sample included EDTA as an anticoagulant and, after arriving
at Duquesne, was stored at -20oC until usage. Reagent grade nitric acid and L-cysteine
were obtained from Fisher Scientific (Pittsburgh, PA). Isotopically enriched

199

Hg2+ and

CH3200Hg+ were obtained from Applied Isotope Technologies, Inc. (Pittsburgh, PA).

Instrumentation/analytical methods:
For microwave sample preparation, a Milestone (Monroe, CT) Ethos 1600
microwave system was used. This system was equipped with temperature feedback
control and magnetic stirring, as well as high pressure (maximum pressure – 100 bar)
closed vessel microwave vessels made of high purity TFM (a thermally resistant form of
fluoropolymer) with a capacity of 100 mL.
For total mercury analysis, a DMA-80 from Milestone (Monroe, CT) was used by
following the guidelines stated in EPA Method 7473 (24). This instrument analyzes a
sample, such as a blood sample, directly without need of sample preparation by thermally
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decomposing it at 750oC such that all of the mercury species are converted to elemental
mercury vapor. This mercury vapor then binds to and is subsequently released by a gold
amalgamator, after which it is analyzed by atomic absorption mass spectrometry.
For analysis of the samples for mercury speciation, LC-ICP-MS analysis was
performed using isocratic elution with a Waters (Milford, MA) Novapak C18 reversed
phase column (150 x 3.9 mm, 4 µm) and a 709 IC polymeric inert pump with an 838
advanced sample processor for automatic sample delivery from Metrohm Peak (Houston,
TX) coupled to an Agilent 4500 ICP-MS (Agilent Technologies, Palo Alto, CA). The
mobile phase consisted of 0.2% cysteine. The flow rate was 1.0 mL/min, and the
injection volume was 100 µl. The chromatography and automation equipment were
situated in a high efficiency particulate air (HEPA) filter class 100 clean hood chamber
next to the ICP-MS in a class 1000 clean room laboratory. Quantification was performed
by monitoring the 199Hg, 200Hg and 202Hg isotopes for the Hg2+and CH3Hg+peaks in the
chromatograms, and isotope ratios for SIDMS analysis were based upon peak area ratios.
Sample preparation was done in triplicate, and four analysis replicates were completed
for each sample preparation replicate (n=12). The isotope ratios were corrected for dead
time, and a solution with natural abundant Hg2+ and CH3Hg+ was also analyzed
periodically between samples to obtain the mass bias correction factors.

Sample preparation
The Stanford blood sample was tested for total mercury with the DMA-80 and
found to have a concentration of 2.70 ± 0.76 ppm. This sample was then spiked with
natural abundant Hg2+ and CH3Hg+ to represent a blood sample with a total mercury
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concentration of ~ 400 ppb. Although this value is much higher than what a normal
human blood sample would have (less than 5 µg/l, or ~ 5 ppb) (25), cases in which blood
mercury concentrations in the triple or quadruple digits ppb have been documented. For
example, Dr. Nilo Arnaiz from the UCLA Department of Medicine reported a case in
which a 37 year old woman who consumed swordfish daily and ended up with symptoms
of mercury poisoning as a result had a blood mercury concentration of 208 µg/l
(approximately 200 ppb) (26). Another case was reported in which a 48 year old man
deliberately consumed a solution of inorganic mercury salt and ended up in the hospital
with mercury poisoning and a blood mercury concentration of 5,200 µg/l (25).
For mercury speciation, to three microwave vessels were each added 0.6000g of
the blood with the elevated mercury, known amounts of 199Hg2+ and CH3 200Hg+, and 10
ml of 4M HNO3. To a fourth vessel was added everything that was added to each of the
other three except the blood so as to serve as a procedural blank. Microwave irradiation
was applied to the samples according to the protocol described in EPA Method 3200 (19)
(2 minute ramp to 100oC, 10 minute hold at 100oC). After cooling, the samples were
filtered through a 0.22 µm filter, then stored at 4oC until analysis.
To mimic what would happen in case of a 25% reduction in recovery, aliquots
were taken from the microwave prepared triplicate samples and diluted 25% with 4M
HNO3. These samples were analyzed using LC-ICP-MS using conditions similar the ones
described earlier in this chapter for the hair studies.

Results and discussion
The results obtained from the SIDMS analyses of both the originally prepared
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samples and the ones prepared so as to mimic a 25% reduction in recovery are shown in
table 4 below (concentrations reported at the 95% C.I.):

Interconversion %

Original
Sample
Sample
mimicking
25% reduction
in recovery

Hg2+ conc. in
ppb

CH3Hg+ conc.
in ppb

Hg2+ to
CH3Hg+

CH3Hg+ to
Hg2+

168 ± 9

Sum of Hg2+
and CH3Hg+ in
ppb
388 ± 16

220 ± 11

1.08% ± 3.01%

1.50% ± 1.55%

218 ± 9

161 ± 11

379 ± 17

2.02% ± 2.74%

0.14% ± 2.06%

Table 4 – Results from analysis of Hg+ and CH3Hg+ in spiked Stanford blood sample

The elevated mercury sample was also analyzed for total mercury using EPA method
7473 as described earlier. The result obtained was 402 ± 39 ppb, which is in agreement
with the results from sum of the mercury species in the SIDMS analyses shown above;
therefore, mass balance was achieved.
Despite the fact that the second set of samples were prepared so as to mimic a
25% reduction in recovery when compared to the original samples, SIDMS analysis
yielded the same results for Hg2+ and CH3Hg+ concentrations from both sets of samples.
This is because the calculations for the concentrations were based, not upon calibration
curves, but upon isotopic ratios which remain constant regardless of the percentage
recovery or the intensity of the signal coming from the mass spectrometer.
Since most human blood samples have mercury species concentrations below 10
ppb, for improved sensitivity, gas chromatography, rather than liquid chromatography, is
often used with ICP-MS for this type of analysis (although, as mentioned earlier, an LC38

ICP-MS method for speciation of mercury in blood has been published – see reference
number 9). A description of mercury speciation analysis in blood using LC-ICP-MS was
described in this section; the next section describes the same kind of analysis using
SPME-GC-ICP-MS.

2B ii – Analysis of Mercury Species in Blood by SPME-GC-ICP-MS using SIDMS

Reagents/Standards
The blood standard used was SRM 966 level 2 bovine blood from the National
Institute of Standards and Technology (NIST, Gaithersburg, MD). This blood standard
was certified for total mercury and had reference values (values not certified due to all of
the potential biases not being accounted for) for inorganic mercury and methylmercury.
The water used for solutions was double deionized (DDI) water from a Barnstead
NANOpure Ultrapure Water System (Dubuque, IA). Reagent grade nitric acid was
obtained from Fisher Scientific (Pittsburgh, PA). Isotopically enriched

199

Hg2+ and

CH3200Hg+ were obtained from Applied Isotope Technologies, Inc. (Pittsburgh, PA).
Sodium tetrapropylborate was obtained from ABCR (Karlsrue, Germany).

Instrumentation/analytical methods:
For microwave sample preparation, a Milestone (Monroe, CT) Ethos 1600
microwave system was used. This system was equipped with temperature feedback
control and magnetic stirring, as well as high pressure (maximum pressure – 100 bar)
closed vessel microwave vessels made of high purity TFM (a thermally resistant form of
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fluoropolymer) with a capacity of 100 mL. Quartz vessels (20 ml) were also used for
implementation of the vessel within a vessel system (to be described in further detail in
the sample preparation section).
For mercury speciation analysis of the prepared samples, SPME-GC-ICP-MS was
used. The SPME equipment consisted of an 85 µm Carboxen/PDMS fiber assembly (part
number 57334-U, Supelco, subsidiary of Sigma-Aldrich, St. Louis, MO), a MicroExtraction holder (part number 57330-U, Supelco, subsidiary of Sigma-Aldrich, St.
Louis, MO), and 20 ml borosilicate glass headspace vials with septa caps (part number
S326-0020, I-CHEM, Rockville, TN). The GC-ICP-MS system consisted of an Agilent
5890 GC connected through a transfer line to an Agilent 4500 ICPMS, and the column
used was an Agilent DB-5, 30 m x 0.25 mm x 0.25 μm (Agilent p/n 122-5032). The
injection port temperature was 150 oC, and the temperature gradient consisted of an initial
2 minute hold at 60 oC, followed by an increase from 60 oC to 120oC (15oC/minute), then
and increase from 120oC to 200oC (20oC/minute), and, lastly, a two minute hold at 200oC.
Quantification was performed by monitoring the 199Hg, 200Hg, and 202Hg isotopes for the
Hg2+ and CH3Hg+ peaks in the chromatograms, and isotope ratios for SIDMS analysis
were based upon peak area ratios. Three sample replicates and three analysis replicates
were completed (n=9). A solution with natural abundant Hg2+and CH3Hg+was also
analyzed periodically between samples to obtain the mass bias correction factors.

Sample Preparation
To a quartz microwave vessel were added a Teflon stir bar, 0.300g of SRM 966
level 2 Bovine blood (certified value for total Hg concentration = 29.8 ± 1.6 ppb, 0.0350g
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of 22.311 ppb 199Hg2+ 0.0350g of 24.374 ppb CH3200Hg+ , and 7.2 g of 2 M HNO3. For
the analytical blank, 0.300g of H2O was used in place of the blood. The small vessel was
put into a larger Teflon vessel with 10 mL of 2 M HNO3, and the vessel was subjected to
microwave irradiation (2 minute ramp to 100oC, 10 minute hold at 100oC). After cooling,
the contents of the vessel were transferred to a centrifuge tube and were centrifuged to
separate particulate matter from the extract. 2 g of the extract were combined with 8 g of
pH 5.2 ammonium acetate buffer (0.287M acetic acid, 0.710M ammonium acetate) and
100 mg of sodium tetrapropylborate in a 20 mL vial (for derivatization). This solution
was stirred at room temperature for ~3 – 5 minutes, after which the SPME fiber (85 μm
Carboxen/PDMS) was inserted into the headspace, and the solution was stirred at 65 oC
for 15 minutes. The SPME was then inserted into the GC-ICP-MS for analysis. Sample
preparation was done in triplicate, as was the analysis (n = 9).

Results and discussion
The results from the mercury speciation analysis of SRM 966 level 2 are shown in
Table 5 (results reported at 95% C.I.):

Experimental Experimental Conversion
Hg2+ conc.
CH3Hg+
of CH3Hg+
(ppb)
conc. (ppb)
to Hg2+

Conversion
of Hg2+ to
CH3Hg+

Experimental Certified
sum of Hg
value for
species (ppb) total Hg
(ppb)
16.7 ± 1.2
15.3 ± 1.5
4%
3%
31.9 ± 2.1
29.8 ±1.6
Table 5 – Results from SIDMS analysis of Hg species in SRM 966 level 2 blood
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The experimental value obtained for the sum of the mercury species (31.9 ± 2.1 ppb) was
in agreement with the certified value for total mercury in SRM 966 level 2 blood (29.8
±1.6 ppb).

Future work
Further work on the speciation of three mercury species (Hg2+, CH3Hg+, and
C2H5Hg+) in blood will be carried out by our research group using SRM 955c level 3
Caprine blood from NIST as a standard, as this standard is certified for the three mercury
species mentioned, as well as total mercury. Preliminary work has already been done
with blood samples from Stanford University that were spiked with Hg2+, CH3Hg+, and
C2H5Hg+ after they arrived at Duquesne University. The chromatogram from one of these
samples in which the final concentration of each species in the blood was ~ 30 ppb is
shown in Figure 3 (signal from 202Hg):
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Figure 3 – Three mercury species measured by SPME-GC-ICP-MS

Preliminary evidence suggests that a significant percentage of the organic mercury
species converted to Hg2+ during the measurement; however, the SIDMS technology can
correct for these transformations. Additionally, to improve sensitivity, more advanced
instrumentation will be used – specifically, an Agilent 7890A GC with an Agilent 7700
ICP-MS.
So far, this chapter has focused on the analyses of mercury species in human
biological matrices to assess toxicological exposure. The methods described in this
chapter can also be used for mercury speciation in environmental samples which can be
potential sources of that exposure. One such matrix for which mercury speciation using
EPA Method 6800 has already been successfully used is soil (27). Another environmental
matrix for which mercury speciation would be important is crude oil, and the usage of
SIDMS for such an analysis is described in the next section.

2C – Mercury Speciation in Crude Oil
The analysis of mercury species in crude oil is important not only for the purpose
of assessing the impact that the oil producers have on the environment, but also for
determining how best to handle the problems associated with mercury species being
present in the equipment used to process the oil. For example, elemental mercury can
form amalgams with certain metals in equipment made from those metals and damage
that equipment as a result (28).
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Our research group obtained two crude oil samples from a major oil company and
analyzed them for total mercury and mercury species extractable by EPA Method 3200.
The description of the procedures used for these analyses is described next.

2C i – Total Mercury and Mercury Speciation in Crude Oil
Reagents/standards:
The water used for solutions was double deionized (DDI) water from a Barnstead
NANOpure Ultrapure Water System (Dubuque, IA). Reagent grade nitric acid, Lcysteine, hydrogen peroxide, pyridine, and methanol were obtained from Fisher Scientific
(Pittsburgh, PA). Nitric acid was purified using sub-boiling distillation in a quartz still
(Milestone, Monroe, CT). Isotopically enriched 199Hg2+, CH3200Hg+, and C2H5201Hg were
supplied by Applied Isotope Technologies (Pittsburgh, PA). The two crude oil samples
were obtained from a major oil company.

Instrumentation/analytical methods:
For microwave sample preparation, a Milestone (Monroe, CT) Ethos 1600
microwave system was used. This system was equipped with temperature feedback
control and magnetic stirring, as well as high pressure (maximum pressure – 100 bar)
closed vessel microwave vessels made of high purity TFM (a thermally resistant form of
fluoropolymer) with a capacity of 100 mL.
For total mercury analysis of the prepared samples, direct analysis was made with
an Agilent 4500 ICP-MS (Agilent Technologies, Palo Alto, CA). Quantification was
performed by monitoring the 199Hg and 202Hg isotopes for IDMS analysis. Three sample
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preparation replicates and four analysis replicates were made for each of the two crude oil
samples.
For analysis of the EPA 3200 extractable mercury species, LC-ICP-MS analysis
was performed using isocratic elution with a Metrohm Peak (Houston, TX) PS-DVB C18
reversed phase column (150 x 4.6 mm, 2 µm) and a model 818 IC polymeric inert pump
with an 838 advanced sample processor for automatic sample delivery from Metrohm
Peak coupled to an Agilent 4500 ICP-MS (Agilent Technologies, Palo Alto, CA). The
mobile phase consisted of a pH 3 solution of 50 mmol/L pyridine, 0.5% (w/v) L-cysteine,
and 5% (v/v) methanol. The flow rate was 1.0 mL/min, and the injection volume was 100
µl. The chromatography and automation equipment were situated in a high efficiency
particulate air (HEPA) filter class 100 clean hood chamber next to the ICP-MS in a class
1000 clean room laboratory. Quantification was performed by monitoring the 199Hg,
200

Hg, 201Hg and 202Hg isotopes for the Hg2+, CH3Hg+, and C2H5Hg+ peaks in the

chromatograms, and isotope ratios for SIDMS analysis were based upon peak area ratios.
Three sample preparation replicates and four analysis replicates were completed. The
isotope ratios were corrected for dead time, and a solution with natural abundant Hg2+,
CH3Hg+, and C2H5Hg+ was also analyzed periodically between samples to obtain the
mass bias correction factors. Three sample preparation replicates and four analysis
replicates were made for each of the two crude oil samples (n=12).

Sample Preparation for total Hg analysis
To a microwave vessel were added a stir bar, 0.5 g of crude oil, a known amount
of 199Hg2+, 9 mL of HNO3, and 2 mL of 30% H2O2. The sample was subjected to
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microwave irradiation using EPA 3052 (29) (ten minute ramp to 180oC, ten minute hold
at 180oC). After cooling, the sample was filtered through a 0.22 mm glass fiber filter and
then stored at 4oC until analysis. Sample preparation was done in triplicate, and two
procedural blanks containing everything that was in the crude oil sample preparation
replicates except the crude oil itself were also prepared.

Sample Preparation for analysis of Hg species extractable by EPA Method 3200
To a microwave vessel were added a Teflon stir bar, 0.5 g of crude oil, known
amounts of 199Hg2+, CH3200Hg+, and C2H5201Hg, and 10 mL of 4 M HNO3. The sample
was subjected to microwave irradiation using EPA Method 3200 (19) (two minute ramp
to 100oC, ten minute hold at 100oC). After cooling, there was a mixture of aqueous
solution and oily residue. The aqueous part of the sample was removed and filtered
through a 0.22 mm glass fiber filter, diluted to 20 mL with DDI water, and then stored at
4oC until analysis. Sample preparation was done in triplicate, and two procedural blanks
containing everything that was in the crude oil sample preparation replicates except the
crude oil itself were also prepared.

Sample preparation for nonextractable Hg Species
The microwave vessels with the oily residues were spiked with known amounts of
199

Hg2+, and to each of them were also added 9 mL of concentrated HNO 3 and 1 mL of

30% H2O2. EPA Method 3052 was implemented (ten minute ramp to 180 o, ten minute
hold at 180o). After cooling and filtering the samples through the 0.22 mm glass fiber
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filters, the samples were stored at 4oC until analysis. A procedural blank was also
prepared with the samples.

Results and Discussion
The total mercury results, extractable mercury species results, and total mercury
results for the oily residues are shown in tables 6, 7, and 8, respectively, on the next page
(results reported at the 95% C.I.):
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Crude oil sample
Total Hg concentration in ppb
Serial # 871833
414.1 ± 24.7
Serial # 870987
432.8 ± 25.4
Table 6 – Total Hg results in Crude Oil

Sample

Deconvoluted concentration
(ppb)

Interconversion %
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Hg2+

CH3Hg+

C2H5Hg+

Hg2+ to
CH3Hg+

CH3Hg+
to Hg2+

CH3Hg+
to
C2H5Hg+

C2H5Hg+
to
CH3Hg+

C2H5Hg+
to Hg2+

Hg2+ to
C2H5Hg+

Serial #
871833

17.3
± 3.6

0.8 ± 0.5

10.7 ± 1.1

9.6 ± 0.9

2.9 ± 0.8

0.8 ± 0.1

6.1 ± 0.6

55.1 ± 0.2

2.1 ± 1.0

Serial #
870987

23.6
± 3.7

0.5 ± 0.1

7.4 ± 2.2

7.4 ± 1.0

6.2 ± 1.0

0.9 ± 0.1

7.9 ± 0.8

86.9 ± 0.5

1.3 ± 0.1

Table 7 – Extractable Hg Species

Sample
Serial # 871833
Serial # 870987

Total nonextractable Hg (ppb)
342.5 ± 46.8
323.9 ± 30.7
Table 8 – Nonextractable Hg

In both crude oil samples, the extractable mercury species constituted about 7% of
the total mercury in the sample. Further research is needed to determine the
nonextractable mercury species. As with ethylmercury in hair, there was a significant
amount of conversion of ethylmercury to inorganic mercury indicated in the speciation
results. SIDMS successfully corrected for this conversion.

2D - Conclusion
The focus of this chapter has been the analysis of mercury species in several
different matrices. Results showed that EPA Method 6800A could correct for
interconversion among mercury species, as well as recoveries of less than 100%. A
critical molecule which the body makes to combat the mercury species mentioned in this
chapter, as well as other xenobiotics, is GSH. This molecule will be the focus of the next
chapter.
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Chapter 3 – Glutathione Speciation

GSH is a tripeptide occurring in most cells of the body, and is involved in several
critical functions, such as antioxidation and heavy metal detoxification (1). Under
conditions of oxidative stress, the active form of GSH, reduced GSH forms a disulfide
dimer, thereby producing GSSG. It has been discussed in the literature that an important
biomarker may be the GSH/GSSG ratio associated with one’s level of oxidative stress,
with lower values for the GSH/GSSG ratio indicating greater oxidative stress levels (2). It
has been observed that children with autism have lower plasma GSH/GSSG ratios, as
well as lower plasma total GSH (tGSH) concentrations compared to healthy controls (3).
Abnormal GSH metabolism has been implicated in other conditions as well, such as
AIDS and diabetes (4).
Several analytical methods have been developed for the analysis of tGSH, GSH,
and GSSG. For tGSH analysis, methods have included spectrophotometric assays (5) as
well as hyphenated techniques, such as LC separation combined with either
electrochemical, fluorescence (6), or mass spectrometry detection (7). Prior to tGSH
analysis, sample preparation typically involves treating disulfide bonds with a reducing
agent, such as dithiothreitol (DTT) (8). For analysis of GSH and GSSG, methods have
included LC separation with either fluorescence or mass spectrometry detection (9). A
derivatization agent, such as NEM, is often used during sample preparation to block the
thiol group on GSH, thereby preventing its conversion to GSSG (10).
In quantitative analysis of tGSH, GSH, and GSSG, the traditional calibration
curve method has been commonly used. Using internal standard (IS) with this method has
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helped to correct for fluctuations in signal intensity For mass spectrometry applications,
one type of internal standard can be an isotopically enriched form of the analyte of
interest. For example, Harwood, et al. used isotopically enriched GSH-NEM and
isotopically enriched GSSG as internal standards for the quantitative calibration curve
based analysis of GSH and GSSG in erythrocytes using LC/MS/MS (11). In their
application, to plot the calibration curves, the x-axis represented the concentration of the
analyte, while the y-axis represented the natural abundant analyte/internal standard peak
area ratio.
Literature values for the GSH/GSSG ratio in healthy adult subjects range from
about 10 to 1 (12), to 200 to 1 (13), to 1000 to 1 (11), as shown in Figure 1 below:

1200

1000 to 1
1000
800

GSH/GSSG

Literature values reported
for red blood cell GSH/GSSG
ratio

600
400

200 to 1

200

10 to 1
0
reference 12

reference 13

reference 11

Figure 1 – Literature values for GSH/GSSG ratio in red blood cells

It should be noted that the method for calculating the GSSG concentration described in
reference 12 was an indirect one which consisted of subtracting the reduced GSH
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concentration from the tGSH concentration. According to Michaelsen, et al., indirect
measurement of GSSG and inadequate prevention of artificial GSSG formation can lead
to inaccurately high results for the GSSG concentration (13).
In our work, an advanced application of isotopically enriched analytes for
quantitative analysis is, as mentioned in chapter 1, EPA Method 6800A (14). One of the
procedures described in this method, IDMS, involves spiking the sample with a known
amount of enriched analyte, performing mass spectrometry measurements on the
prepared sample, and calculating the concentration of the analyte based on peak area
ratios. No traditional calibration curves are used in this method. An application of IDMS
for tGSH analysis in red blood cells will be described later in this chapter. A more
advanced procedure described in EPA Method 6800A, speciated isotope dilution mass
spectrometry (SIDMS), involves spiking the sample with known amounts of the enriched
analytes of interest (and pairs of related analytes), analyzing the sample by mass
spectrometry, and determining concentrations and extent of species interconversion by
analyzing analyte MS peak ratios. This method can be used for GSH/GSSG analysis, as
GSH to GSSG conversion can occur during sample preparation (although there are
techniques for minimizing this conversion, which will be discussed later), and correction
of the conversion is necessary to assess the analytes accurately. This application of
SIDMS for optimizing GSH and GSSG analysis was a major part of my research and this
PhD project, as was the application of IDMS for optimizing tGSH analysis.
In a collaborative project with the Kingston research group of Duquesne
University and the Children’s Institute in Pittsburgh, IDMS was used for the analysis of
tGSH, and SIDMS for the analysis GSH and GSSG, in red blood cells from autistic
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children before and after exposure to a therapeutic cleanroom environment (this
collaborative project will henceforth be referred to as the “cleanroom study”). A second
collaborative project involving the same kinds of analyses for a set of 30 control and 30
autistic patients was also undertaken (this second collaborative project will henceforth be
referred to as the “red blood cell study”). This application of the developed measurement
methods in these studies is described next.

3A – Analysis of tGSH, GSH and GSSG in Red Blood Cells from Autistic Children
Exposed to Cleanroom

Materials and Methods
Cleanroom Study and Red Blood Cell Study Samples
Both the cleanroom and red blood cell studies were funded with grants obtained
by Professor Kingston in collaboration with Dr. Scott Faber (M.D.) of The Children’s
Institute. Both studies were IRB approved, and the grants for them were registered with
both institutions. In the cleanroom study, blood samples from ten autistic children were
taken before and after a two week clean room exposure (12 hours per day). These
samples were obtained in the child’s home from a registered phlebotomist, Ms. Becky
Pekar. Following the sample handling procedure described by Michaelsen, et al. for
minimizing GSH oxidation, the blood was drawn from the vein into tube containing
anticoagulant (Na2EDTA) and immediately put on ice and protected from light, (13). As
these were regional studies, all patients were within a one-hour driving distance of
Duquesne and The Children’s Institute; thus, samples could be transported to Duquesne
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within 2 hours. All patients were within one hour driving distance of Duquesne and The
Children’s Institute as these were regional studies. The samples were aliquoted into tared
1.7 mL polypropylene microcentrifuge tubes from VWR (Randor, PA, part number
87003-284) under inert atmosphere (Nitrogen) conditions. For the first 6 cleanroom
samples, either a nitrogen glove box shared by others in the Chemistry Department at
Duquesne or a nitrogen glove bag was used; for the rest of the samples, a dedicated
nitrogen glove box specifically for the Kingston research group was used. The samples
were then centrifuged using a Sorvall Discovery M150 SE centrifuge with an S120AT2
rotor (ThermoFisher, Asheville, NC) at 2,000 x g at 4oC for 15 minutes to separate the
plasma from red blood cells. The plasma layer above the red blood cells was removed
and transferred to microcentrifuge tubes, then the small buffy coat containing the white
blood cells which remained above the red blood cells was removed and discarded. The
red blood cell and plasma samples were weighed on an analytical balance, then, placed
into the -80oC freezer for storage.

Chemicals/Reagents
Isotopically enriched GSH with two 13C’s and one 15N and isotopically enriched
GSSG with four 13C’s were obtained from Cambridge Isotope Laboratories (Andover,
MA). With both enriched standards, the enrichment was on the glycine. Natural abundant
GSH was obtained from Sigma-Aldrich (St. Louis, MO, p/n G4251-10G). Natural
abundant GSSG was obtained from Sigma (p/n G4501-1G). HPLC grade acetonitrile was
obtained from Sigma-Aldrich (p/n 27,071-7). ammonium formate and 88% formic acid
were obtained from Fisher Scientific (Pittsburgh, PA – p/n’s A666-500 and A118P-500,
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respectively). DTT and NEM were both obtained from Sigma-Aldrich (p/n’s D5545-5G
and E1271-5G, respectively).

Equipment
The column used for both the tGSH analysis and the GSH/GSSG analysis was a
Waters Atlantis HILIC Silica, 3µm, 2.1 x 100 mm (Waters Corporation, Milford, MA,
p/n 186002013). The system used for LC/MS/MS analysis was an Agilent 6460 Triple
Quadrupole Mass Spectrometer with an Agilent 1200 HPLC system and Mass Hunter
software (Agilent Technologies, Santa Clara, CA). For the analysis of the samples using
the autosampler, polypropylene 96 well plates with 0.5 mL wells (Agilent p/n 5042-1386)
and silicone coverings with pre-slit well caps (Thermo Scientific, p/n 276011) were used.
For the pre-concentration of sample solutions by evaporating off the solvent and
redissolving in a smaller volume, a SpeedVac (made by what was formerly Savant, now
Thermo, model number SVC 100D) was used for evaporation purposes. For
centrifugation of the samples after protein denaturation, the Sorvall Discovery M150 SE
centrifuge with the S120AT2 rotor (Thermo Scientific) was used. Polypropylene
microcentrifuge tubes (1.7 mL) were obtained from VWR (Randor, PA, part number
87003-294).

Sample Preparation for the analysis of tGSH
Frozen aliquots of the red blood cells were removed from the -80oC freezer and
thawed. 30.0 mg of sample were added to 1.7 mL polypropylene microcentrifuge tubes
and treated with 30.0 mg of 2.09 µmol/g isotopically enriched GSH. The concentration of
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the enriched GSH in the solution that was added to the red blood cells was determined by
a procedure known as reversed isotope dilution mass spectrometry (RIDMS), which will
be described in more detail later in this chapter). Also added were 300 mg of a freshly
made aqueous solution of ~ 10,000 ppm DTT. After 20 minutes, ~ 1 mL of acetonitrile
was added to denature the proteins, and the samples were centrifuged at 4 oC at 5,000 x g
for 10 minutes. The supernatants were removed and used for analysis by LC/MS/MS.
Sample preparation was done in triplicate, and analysis was done in duplicate for a total
of six replicate analyses, (n=6). For method validation, an aqueous solution of GSH with
a known concentration 2.30 µmol/g was analyzed as well.

Sample preparation for analysis of GSH and GSSG
The red blood cell sample in the 1.7 mL microcentrifuge tube (mass of sample in
the tube was already known before removal from the freezer, usually ~400 mg) was
treated with 800 µL of ~ 8,000 ppm NEM in a nitrogen glove box while thawing, and a
250 mg aliquot of this NEM treated sample was spiked with 40.0 mg of 2.95 µmol/g
isotopically enriched GSH. The sample was also spiked with 35.0 mg of a solution of
enriched GSSG that had been diluted 50 fold with H2O just before spiking (original
concentration of enriched GSSG stock solution – 1.95 µmol/g). The concentrations of
enriched species were determined by RIDMS, described in more detail later in this
chapter. Each sample was allowed to equilibrate for 30 min, after which it was treated
with HPLC grade acetonitile to denature the proteins, then centrifuged at 5,000 x g for 3
min at 4 oC. The supernatant was removed, the solvent from the resulting supernatant was
evaporated off using a SpeedVac at medium heat (40 oC), and the resulting residue was
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dissolved in 30 µL of DDI H2O, after which ~ 100 µL of HPLC grade acetonitrile were
added. This final solution was used for analysis. Sample preparation was done in
triplicate, and analyses in duplicate (n=6). For method validation, an aqueous solution
containing known concentrations of reduced GSH (2.00 µmol/g) and GSSG (0.0601
µmol/g) was made and analyzed as well.

Preparation of aqueous solutions of the enriched GSH and GSSG
Both enriched GSH and GSSG are very expensive. 50 mg of the former costs over
$700, and 50 mg of the latter costs over $2,000. One way to use both in a cost efficient
manner is to use only a few mg to make aqueous solutions of each of them, aliquot those
solutions into 1.7 mL polypropylene tubes, and store those tubes with the solutions in the
-20o C freezer. Studies have shown that aqueous solutions of GSH and GSSG to be used
for analysis can be stored for months at -20oC (5, 15). Because the low mass of enriched
material used can lead to greater uncertainty in the concentration calculation, one can
instead analyze the concentrations of the solutions by taking aliquots of them out of the 20oC freezer and determining the concentrations of them using RIDMS, which is
described in EPA Method 6800a (14). To use this method for the calibration and
validation of the enriched GSH, for example, an aqueous solution of known concentration
of natural abundant GSH (which is relatively inexpensive) was made, and a known
amount of this solution was used to spike a known amount of the frozen and thawed
solution of enriched GSH. The spiked solution was then treated with DTT, followed by
Acetonitrile, just as in the tGSH sample preparation protocol. The solution was then
analyzed by LC/MS/MS using the same method that was used for the tGSH analysis,
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described below. Sample preparation was done in triplicate, and analysis in duplicate (n =
6). The RIDMS calculation is done exactly the same way as the IDMS calculation is with
the exception that the natural abundant GSH is now considered the enriched form and the
enriched GSH is now considered the natural abundant form. Enriched GSSG can be
analyzed in a similar manner using inexpensive natural abundant GSSG, with the
exception that no DTT is used, and can be analyzed using the same LC/MS/MS protocol
as used for the analysis of the GSSG in the red blood cells, described in the next section.

LC/MS/MS Analysis Conditions for the tGSH analysis
As mentioned earlier, an Agilent (Santa Clara, CA) 6460 Triple Quadrupole Mass
Spectrometer coupled to an Agilent 1200 Series LC system was used for the analysis.
The column used was a Waters (Milford, MA) Atlantis HILIC Silica (3µm, 2.1 x 100
mm), with mobile phase A consisting of 20 mM ammonium formate, pH 3.8, and mobile
phase B consisting of HPLC grade acetonitrile. The column temperature was 45 oC, and
the solvent flow rate was 0.35 mL/minute. The nebulizer gas (nitrogen) temperature was
300oC, and its flow rate was 8 L/minute. The sheath gas (nitrogen) temperature was
250oC, and its flow rate was 11 L/minute. The injection volume was 1 µl, and isocratic
elution was used. Transitions monitored in positive mode included 308 m/z → 179 m/z
(for natural abundant GSH) and 311 m/z → 182 m/z (for isotopically enriched GSH). The
product ion of interest was one resulting from the loss of one pyroglutamate, 129 amu).
The collision energy was 12V, the capillary voltage was 3500V, the fragmentor voltage
was 135V, and the dwell time was 50 ms.
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LC/MS/MS Analysis Conditions for the GSH/GSSG analysis
An Agilent (Santa Clara, CA) 6460 Triple Quadrupole Mass Spectrometer
coupled to an Agilent 1200 Series LC system was used for the analysis. The column used
was a Waters (Milford, MA) Atlantis HILIC Silica (3µm, 2.1 x 100 mm), with mobile
phase A consisting of 20 mM ammonium formate, pH 3.8, and mobile phase B consisting
of HPLC grade acetonitrile. The column temperature was 45 oC, and the solvent flow rate
was 0.35 mL/minute. The nebulizer gas (nitrogen) temperature was 300oC, and its flow
rate was 8 L/minute. The sheath gas (nitrogen) temperature was 250 oC, and its flow rate
was 11 L/minute. The injection volume was 5 µl, and the gradient used is described in
table 1 below:

Time

% 20 mM
% Acetonitrile
Ammonium formate
buffer
0 minutes
25
75
10 minutes
50
50
16 minutes
50
50
20 minutes
25
75
25 minutes
25
75
Table 1 – Gradient system for HILIC method

Analysis was done in positive mode, and the collision energy used for tandem MS
purposes for the GSH-NEM complex (which resulted in the primary product ion being
one with the loss of pyroglutamate) was 12V, and that for GSSG (resulting in the loss of
two pyroglutamates) was 25V. The transitions monitored included 433 m/z → 304 m/z
(for natural abundant GSH-NEM), 436 m/z → 307 m/z (for isotopically enriched GSHNEM), 613 m/z →355 m/z (for natural abundant GSSG), 616 m/z → 358 m/z (for
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possible “hybrid” GSSG), 617 m/z → 359 m/z (for isotopically enriched GSSG with four
13

C’s), and 618 m/z → 361 m/z (for possible enriched GSSG completely from enriched

GSH). The retention time for the GSH-NEM complex was ~ 3 minutes, and that for the
GSSG was ~ 8 minutes. The capillary voltage was 3500V, the fragmentor voltage was
135V, and the dwell time was 50 ms.

Results and Discussion (Note: All results reported at the 95% C.I.)
Method Validation
For the validation of the method for the analysis of tGSH concentration, the
experimental value obtained, 2.09 ± 0.30 µmol/g, was in agreement with the known value
of 2.30 µmol/g. For validation of the method for analysis of reduced GSH and GSSG, the
experimental values obtained, 2.27 ± 0.32 µmol/g and 0.0623 ± 0.0028 µmol/g,
respectively, were in agreement with the corresponding known values of 2.00 µmol/g and
0.0601 µmol/g.

Results from cleanroom study
The tGSH and GSH/GSSG results from the cleanroom study are shown in Figures 2 and
3, respectively.
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Figure 2 – Results from tGSH analysis from the cleanroom study

Figure 3 – Results from the GSH/GSSG analysis from the cleanroom study

In the clean room study, in the tGSH analysis, no overall change was noticed in
the before and after tGSH values for the children. Regarding the GSH/GSSG ratio
analyses, children 6 and 8 are young identical twins girls. The former twin (child 6) had
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an increase in the GSH/GSSG ratio. This twin (child 6) showed improvement with
respect to behavioral characteristics as well (data for behavioral characteristics not
shown), while the latter (child 8) did not. It was hypothesized that the improvement in
behavior in child 6 and the absence of such an improvement in child 8 was related to the
improvement or lack thereof in the GSH/GSSG ratio. An epigenetic relationship was also
hypothesized, but a conclusive statement regarding such a relationship for the explanation
of the results from children 6 and 8 is beyond the scope of this discussion. Such a
relationship between development of autism and possible epigenetic factors has been
documented in the literature and in the examples documented in “Ghost in Your Genes” a
documentary relating epigenetics and environmental factors presented by NOVA (16). In
the NOVA documentary, a case was described involving identical twin sisters of whom
one twin had autism while the other did not. Environmental factors and epigenetics were
considered possible contributing factors by researchers in the documentary, and these
same factors are related to the study results discussed here.
Although there was a relatively small sample size (n=10) used in the cleanroom
study that limited the statistical power and made it difficult to make strong, conclusive
statements about the results obtained, our research group is, as of this writing, conducting
a much larger study involving 30 autism patients and 30 healthy controls matched for
age, gender, and socioeconomic status. This study is described next.

66

3B – Analysis of tGSH in Red Blood Cells from 16 Pairs of Age, Gender, and
Socioeconomic status matched autistic and control samples

In an ongoing study which will eventually include 30 young autism patients and
30 matched healthy controls, blood samples from 16 autism patients and 16 age, gender,
and socioeconomically matched healthy controls were delivered to Duquesne University
and processed so as to obtain the red blood samples just like the cleanroom samples were.
As of this writing, from the perspective of the author, this is still a blind study, as
information pertaining to which children are the controls and which are autistic is being
withheld until the end of the study. These 32 samples were prepared for tGSH in a
manner similar to that used for the analysis of the tGSH in the cleanroom samples. To a
1.7 mL polypropylene microcentrifuge tube were added 20.0 mg of thawed and
vigorously shaken (for ~ 3 – 5 seconds) 2.31 µmol/g isotopically enriched GSH, 18.0 mg
of thawed red blood cell sample, and 160 mg of freshly made ~10,000 ppm DTT. After
allowing the sample to equilibrate for 30 minutes, 0.6000 g of HPLC grade Acetonitrile
were added to denature the proteins. The sample was centrifuged at 4 oC at 5,000 x g for
10 minutes, and the supernatant was removed and used for analysis. Sample preparation
was done in triplicate, and analysis of each replicate in duplicate (n=6). The LC/MS/MS
method used for tGSH analysis was also similar to that used for the cleanroom study
except that the concentration of pH 3.8 ammonium formate was 10 mM instead of 20
mM. It had been noticed by our research group that, as the concentration of ammonium
formate in the solution used as solvent A for the LC/MS/MS method increases, peak in
the chromatogram becomes more narrow and the signal intensity decreases; conversely,
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as the concentration of ammonium formate decreases, the peak becomes broader and
more intense (data not shown). The changing of the ammonium formate concentration
was intended to optimize the peak width/signal intensity relationship, taking into account
other parameters, such as the number of SRM transitions. The results of the analysis of
these 16 pairs of samples are shown in Figure 4 on the next page:
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tGSH analysis in red blood cells from 16 matched pairs of control and autistic samples from red blood cell
study (p = 0.012)
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Figure 4 – Results from the tGSH analysis of red blood cells from 16 matched pairs of control and autistic samples
from the red blood cell study

The results in Figure 4 were sent to our statistician, Dr. John Kern from Duquesne
University. He reported that, overall, collectively, the autistic patients had higher red
blood cell tGSH than the healthy controls (although there was some overlap), and the
difference was statistically significant (p=0.012). As mentioned in the introduction, a
study by Adams et al. in which GSH in red blood cells and heavy metals in urine from
autistic children were analyzed before and after chelation therapy suggested that exposure
to toxic metals other than mercury, such as lead, aluminum, cadmium, and antimony
results in higher than normal GSH levels due to the body’s increased GSH synthesis in
response to exposure to those metals, while exposure to mercury results in lower than
normal GSH levels, possibly due to the inhibition of GSH synthesis by the mercury (17).
The study also suggested that, as the body burden of toxic metals is lowered, the
concentration of GSH in red blood cells normalizes (17). The results obtained thus far in
our red blood cell study suggest the possibility, but do not yet prove, that the autistic
patients in our study have, on average, a higher body burden of toxic metals other than
mercury which resulted in their bodies making more GSH in response to exposure to
those toxic metals. Further research is needed to confirm this hypothesis. Figure 5 is a
statistical extension and interpretation of the logistic regression analysis of tGSH in red
blood cells vs. autistic diagnosis probability for 32 children. The calculations used for
Figure 5 were performed by the statistician on our research team, Dr. Kern.
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tGSH in red blood cells (µmol/g)
Figure 5 – Statistical extension and interpretation of the logistic regression analysis of
tGSH in red blood cells vs. autistic diagnosis probability for 32 children (n= 16 matched
pairs).

The graph is based on the overall probability of a 1, 2 or 3% chance of having an autistic
child in a population such as Western Pennsylvania. To explain further, if the overall
prevalence of autism in western Pennsylvania is, for example, 2% (blue line), the
probability of a child with a red blood cell tGSH concentration of 1.8 µmol/g having
autism is extremely low (no more than a random sample from the general population),
but increases as the tGSH concentration increases such that, at a concentration of 2.6
µmol/g, for example, the diagnostic probability exceeds 15%.
Our research group is following up on this work by analyzing the remaining 14
pairs of control and autistic samples for red blood cell tGSH, as well as all 60 red blood
cell samples (30 control and 30 autistic) for GSH/GSSG analysis. While the GSH/GSSG
ratios for these same patients were not available at the time of this chapter presentation,
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this data is being accumulated and will, very likely, be presented as a final addendum to
this chapter.
In both the cleanroom study and the red blood cell study, although steps were
taken to minimize the conversion of GSH to GSSG in the blood samples prior to their
arrival at Duquesne, such as drawing the samples into blood draw tubes via vacuum
suction without exposing them to atmospheric oxygen, keeping the samples in ice, and
protecting them from light during transport, additional work is currently being carried out
by our research group to improve this methodology so that whole blood samples obtained
from nonlocal settings can also be analyzed for both tGSH and GSH/GSSG. In addition,
research into enabling long distance transport of these blood tubes with correction by
field and remote automatic spiking is being carried out at the present time. The progress
made so far in this area by our research group is described next.

3C – Enabling sampling of tGSH and GSH/GSSG in blood sample from remote
locations
A recent paper by Rossi, et al, describes using a blood draw tube containing
Na2EDTA (anticoagulant) and NEM for the purpose of preventing the conversion of GSH
to GSSG after the blood is drawn into the tube and transported to the nonlocal laboratory
for analysis (18). Although their experiments included only the analysis of reduced GSH
(specifically, GSH conjugated with NEM) and did not include GSSG analysis, they did
demonstrate the potential for obtaining samples from nonlocal settings for reduced GSH
analysis. Our research group at Duquesne University, in collaboration with Applied
Isotope Technologies (AIT – Pittsburgh, PA), and the Open Medicine Institute (Mountain
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View, CA), is continuing the remote measurement work by preparing a blood draw tube
containing Na2EDTA and a solution containing NEM, isotopically enriched GSH, and
isotopically enriched GSSG, and using this blood draw tube to obtain and analyze a blood
sample from a nonlocal setting. The details of this protocol are described next.

Materials and Methods
The same reagents used in the cleanroom and red blood cell studies for sampling
and quantifying of tGSH and GSH/GSSG were used in this study. A solution containing
~ 4,000 ppm NEM, 0.919 µmol/g enriched GSH, and 0.00317 µmol/g enriched GSSG
was made and put into a 7 ml capacity blue capped blood draw tube containing 10.5 mg
of Na2EDTA as an anticoagulant (tube provided by Kendall, which is now part of
Covidien, Mansfield, MA). This prepared blood draw tube, along with a second and third
tube containing just the Na2EDTA, were weighed and then shipped frozen to the hospital
clinical laboratory run by Dr. Andreas Kogelnik MD, PhD, Medical Director.of the Open
Medicine Institute in Mountain View California. The staff at the Open Medicine Institute
followed the procedure given to them, which is shown below in a protocol that was
provided as a standard operating procedure (SOP):

Standard Operating Procedure for Blood Draw Tubes for tGSH and GSH/GSSG
(begin official SOP document)

Standard Operating Procedure (SOP) for GSH Test Assay
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Blood Draw Tubes for total Glutathione, reduced Glutathione and Glutathione
Disulfide Test
AIT-GSH-GSSG-α

PURPOSE

To measure the concentrations of total glutathione (tGSH), reduced
glutathione (rGSH) and glutathione disulfide (GSSG) in whole blood.

PRINCIPLE

The values for tGSH and the rGSH/GSSG ratio are often used as
indicators of the extent of one’s oxidative stress level and have
applications to autism, chronic fatigue syndrome, cancer, and other
conditions.
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APPLICATION Blood samples are drawn into specialized tubes by the phlebotomist,
then, following the procedure below are sent to AIT for analysis.

The procedure involves the usage of N-Ethylmaleimide (NEM)
already present in the blood draw tube designated for the analysis of
the rGSH/GSSG ratio. The purpose of the NEM is to block the thiol
group on rGSH and, thereby, prevent the conversion of it to GSSG.
Isotopically enriched rGSH and GSSG, as well as Disodium EDTA,
are also present in the tube designated for rGSH/GSSG analysis.
Disodium EDTA is present in the tube for tGSH analysis.

LINKED

The MSDS’s for NEM, GSH, GSSG, and Disodium EDTA are on file

DOCUMENTS

and available upon request.

RELATED

The procedure for preparing the blood draw tube for rGSH/GSSG

DOCUMENTS

analysis is similar to one described by Rossi, et al. (Analytical
Biochemistry, 2011, 415, 81-83).
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SPECIMEN

Required specimen is the blood samples that need to be drawn to

REQUIREMENT

the correct tubes at the specified among, by following the SOP

AND
detailed in this document.
PREPARATION

Supplied by AIT:
MATERIALS
AND

1. One blood draw tube labeled “throw away,” with code “aaag”

EQUIPMENT

2. One blood draw tube labeled “tGSH” with code “aaah”
3. One blood draw tube labeled “rGSH/GSSG” with code ”aaaj”
4. Three pieces of bubble wrap to be used for re-packing the tubes
5. Ziploc bags with special packing material, to be used for repacking tubes
6. Federal Express form to be used to ship the tubes back to AIT
7. Cold packs

Supplied by the customer: Facility, blood draw equipment (syringe, needle, etc.), -20 oC
freezer, phlebotomist
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QUALITY

This SOP is a part of final test development project conducted by

CONTROL/

AIT which supplies all the material and implement quality

QUALITY

assurance protocols associated with this project.

ASSURANCE

DEFINITIONS

rGSH→ reduced glutathione,
GSSG → glutathione disulfide,
tGSH → total glutathione
NEM→N-Ethylmaleimide, MSDS → Material Safety Data Sheet

PROCEDURE

1. Upon taking delivery, inspect the package for visible, substantial damage to the box.
Call AIT (408-472-2333), if damage is observed.
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2. Open the box without damaging it so that it can be re-used to return the samples.
Examine the contents – especially the three blood draw tubes (one with a frozen solution
inside) – for damage and/or leaks that can be observed by eye. Please see the packing list
at the end of this document. Call AIT, if tubes are damaged or leak occurred during
transit. Save all the contents of the box, including the packing material.

3. Put the entire box in a –20oC freezer until ready for use. Alternatively, remove the
contents – blood draw tubes – in container or a tube rack, and put the container in a

–

20oC freezer until ready for use. Make sure the tubes are placed in the container stored
upright in the freezer.

4. Approximately 20 minutes before the blood is scheduled to be drawn, take the three
tubes out of the freezer.
Note: Keep the ice-packs in the freezer, so they will be ready to use when
samples are re-packed for shipment back to AIT.

5. Place the rGSH/GSSG tube (with the 3 mL of solution) into a Ziploc bag, then place
the tube in the bag upright into a beaker with ambient temperature water to thaw the
solution inside the tube. After the solution is thawed, gently invert the tube 3 to 4 times to
facilitate mixing.
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6. Draw approximately 3 mL of blood from the antecubital vein into the “throw-away”
tube and discard the tube. The throw-away tube should be at least half full. This
approximates to about 3 mL volume.

Note: If blood is to be drawn from the patient in sequence with another draw, the
throw-away will not be needed as long as the draw for GSH test assay is done
after another draw using the same needle under use.

7. Using the same blood draw needle in the antecubital vein, draw 6 mL of blood into the
tGSH tube, then draw approximately 3 mL of blood into the rGSH/GSSG tube containing
3 mL of solution already in it.

8. Mix the contents of the tubes by gently inverting them several times, over the course of
5 minutes.

9. Put the tubes back into the -20oC freezer for storage for a minimum of 2 hours.

10. Ship the samples back to AIT, overnight, with ice packs, in the same insulated box
that the tubes came in. Specifically, wrap each of the tubes in the supplied bubble wrap,
put the wrapped tubes along with absorbent paper towels into the small Ziploc bag, seal
the small Ziploc bag, put the small Ziploc bag along with two frozen cold packs into the
large Ziploc bag, seal the large Ziploc bag, put the large Ziploc bag into the styrofoam
box with the shock absorbent material so that the bag is in the center of the box, put the
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Styrofoam cap on top of the Styrofoam box, put the Styrofoam box back into the
cardboard box, and tape up the cardboard box with packing tape. Label the outside of the
cardboard box with the following return address: Applied Isotope Technologies, 2403
Sidney Street, Ste-280, Pittsburgh, PA 15203. Also, label the outside of the box “Exempt
Human Specimens.”

CALCULA-

Mass spectrometric sample analyses will be carried out by the AIT

TIONS

staff.

RESULTS/

The data will be obtained and interpreted by the staff at AIT. Final,

INTERP

tabulated results will be reviewed and approved by Prof. Skip

-RETATION

Kingston.

REFERENCES

The GSH test was developed by applying Speciated Isotope Dilution
Mass Spectrometry (SIDMS), a technology codified in RCRA EPA
Method 6800. Additional information may be obtained by contacting
AIT:
Matt Pamuku
Ph: 408-472-2333
E: matt@sidms.com
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DOCUMENT CONTROL

Author:

Timothy Fahrenholz Reviewed by: Matt Pamuku Approved by: Skip

Kingston, Ph.D.
Signed: Signed copy on file

Signed: Signed copy on file

Date: August 30, 2011

Signed: Signed copy on file

Date: August 30, 2011

Date: August

30, 2011

Revision: V-1.02.01
Part No: TBD
ADDITIONAL INFORMATION
AIT reserves the right to correct all technical specifications, descriptions, protocols,
material, deliveries, prices and correct typos, without notice.

This test is still under beta-level development. The recipient agrees to cooperate with AIT
to accomplish its testing goals. AIT offers no warranties, implied or expressed, and fitfor-purpose statements associated with this test. The recipient agrees to cooperate with all
terms and conditions.

PACKING LIST
Blood draw tube

Acceptable condition? (for the tubes, no
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cracks, leaks, etc) Circle one.
1. Tube labeled “Throw

yes/no

Away”
2. Tube labeled “tGSH”

yes/no

3. Tube labeled

yes/no

“rGSH/GSSG”
4. Bubble Wrap

yes/no

5. Ziploc Bags

yes/no

6. FedEx Instructions

yes/no

7. FedEx Shipping Form

yes/no

8. Cold Packs

yes/no

(End of official SOP document)

After receiving the three blood draw tubes with the blood in them from the Open
Medicine Institute, the tubes were inspected, and no noticeable damage was observed.
The tubes were stored at -20oC until sample preparation/analysis.

Sample Preparation and Analysis of tGSH in whole blood sample from Open Medicine
Institute
The sample preparation protocol for the analysis of tGSH in the whole blood
sample was similar to that used for the analysis of tGSH in red blood cells described
earlier. The blood sample was removed from the -20oC freezer and thawed. To each of
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three 1.7 mL polypropylene tube were added ~ 60.0 mg of whole blood , ~ 15.0 mg of
2.18 µmol/g enriched GSH, and 150 mg of 10,000 ppm DTT for triplicate sample
preparation. After 30 minutes, 600 mg of acetonitrile were added to each tube to denature
the proteins, and the sample preparation replicates were centrifuged at 5,000 x g at 4 oC
for 10 minutes, after which the supernatants were removed and used for LC/MS/MS
analysis. Sample preparation was done in triplicate, and analysis in duplicate (n=6).
For LC/MS/MS analysis, the conditions used were similar to those used the for
the tGSH analysis in the red blood cell study described earlier in this chapter.

Sample Preparation and Analysis of GSH and GSSG in whole blood sample from Open
Medicine Institute
In a personal communication with Dr. Andrew Alpert (one of the world experts in
hydrophilic interaction chromatography, or HILIC) from Poly LC, Inc., at the 2011
Pittcon in Atlanta, to improve the sensitivity for the analysis of GSSG, he suggested that,
in the sample preparation protocol, after evaporating off the solvent with the SpeedVac,
instead of initially redissolving the residue in water, one should redissolve it in the
ammonium formate buffer solution used as solvent A in the LC/MS/MS method to help
with the ionization (19). In another personal communication with Brian Rappold from
Labcorp at the 2011 American Society for Mass Spectrometry (ASMS) Conference in
Denver, Colorado, he suggested the usage of a mixture of ethyl acetate and acetonitrile
(e.g. 10% ethyl acetate), rather than 100% acetonitrile, as solvent B in the LC/MS/MS
protocol, which would help in the evaporation of the solvent mixture in the electrospray
droplet and, thus, help improve sensitivity (20). In a PowerPoint® presentation that he
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gave at the conference, he described using this method to achieve up to a five-fold
improvement in sensitivity. During a September 2011 mass spectrometry training course
at Duquesne University given by Dr. Richard King from Pharmacadence Analytical
Services, LLC, he suggested that, for improving the sensitivity in a given method, one
way would be decrease the dwell time in the triple quadrupole mass spectrometer (e.g.
from 50 ms to 5 ms) and, thus, obtain more points per peak (21). These three suggestions
were implemented in the protocol for analyzing GSH and GSSG in the whole blood
sample sent back to Duquesne by the Open Medicine Institute.
More specifically, for sample preparation, the GSH/GSSG tube from Dr.
Kogelnik’s hospital clinical laboratory was thawed, and 200 µL aliquots of the spiked
blood were added to five 1.7 mL polypropylene microcentrifuge tubes. To each tube were
added 800 µl of acetonitrile to denature the proteins, and these five tubes were
centrifuged at 5,000 x g at 4oC for 10 minutes. The supernatants were transferred to clean
1.7 ml polypropylene tubes, and these tubes were put on the SpeedVac for evaporation at
medium heat (~40oC) for 1 hour and 45 minutes. After evaporation, to the first tube with
the residue were added 40 µL of 20 mM ammonium formate, pH 3.8, which was pipetted
up and down in the tube ~ 4 times, after which the solution in the first tube was
transferred to the second tube, where the up and down pipetting technique was repeated,
and so on, down to the fifth tube, so that the residues from all five tubes were pooled. To
the tube with the solution of pooled residue were added 60 µL of acetonitrile, and the
solution was analyzed using conditions similar to those used for the GSH/GSSG analysis
in red blood cells described earlier in this chapter except that solvent B in the LC/MS/MS
protocol consisted of 90% acetonitrile and 10% ethyl acetate (Optima brand, Fisher
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Scientific, p/n E196-4) and the dwell time was lowered from 50 ms to 5 ms. Four
analysis replicates were completed (n=4).

Results and Discussion
The concentration of tGSH was 1.21 ± 0.7 µmol/g, and that of reduced GSH was
1.27 ± 0.2 µmol/g. The values for the tGSH and reduced GSH were, thus, statistically
indistinguishable. GSSG was detected in two of the four runs, and its calculated
concentration ranged from 1.60 nmol/g on the high end to ND (not detected). The
chromatogram from one of these runs is shown in Figure 6. The peaks for the transitions
of natural abundant GSSG (613 m/z → 355 m/z) and the spiked enriched GSSG (617 m/z
→ 359 m/z) were weak, as were the peaks for the “hybrid sandwich” (transition – 616
m/z → 358 m/z) and the “white bread sandwich” (transition – 619 m/z → 361 m/z).
Although further research is needed to improve the sensitivity for GSSG detection, these
results represent a step toward the goal of performing direct quantitation of GSSG, as
well as GSH, in a whole blood sample from a nonlocal setting using SIDMS technology.
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613.1 m/z → 355.1
m/z

616.1 m/z → 358.1
m/z -

617.1 m/z → 359.1
m/z

619.1 m/z → 361.1
m/z

Figure 6 – GSSG transitions in LC/MS/MS chromatogram from analysis of spiked whole
blood sample

Researchers, such as Steghens, et al. have found the concentration of GSSG to be
significantly lower (7 – fold) in whole blood samples than in red blood cells from healthy
adults, thereby making the detection of it in the former matrix more difficult than in the
latter one (22). The Steghens research group analyzed blood samples from 20 healthy
adults for reduced GSH and GSSG concentration using LC/MS and found the mean
reduced GSH concentration to be 1.31 ± 0.12 mM and the mean GSSG concentration to
be 0.64 ± 0.22 µM. They, too, found the analysis of GSSG in whole blood to be difficult,
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as evidenced by the mean S/N ratio reported being between 5 and 6 for the analysis of
GSSG in the 20 samples. Future work in our research group will involve further
optimization of our method for analysis of the GSH/GSSG ratio in whole blood for our
remote blood draw tube project.
As discussed, GSH forms conjugates with various species of mercury. That being
the case, the development of methods for the analysis of such conjugates in the body
would complement the analysis of GSH. An important step toward this end would be the
initial development of methods for quantitatively (not just qualitatively) analyzing these
conjugates in simple matrices so that those methods can be further modified for more
complex matrices, such as blood, plasma, and urine. GSH holding the conjugate toxicants
is one set of analytes for which quantitative analysis may aid in diagnosis and treatment
of several conditions. Since GSH is a first line of defense in the immune system and is a
major detoxification mechanism in the human body, investigating quantification of
glutathione with the toxicant was another major scope of assessment in this research.
Methods for these kinds of analyses in simple aqueous matrices are described in the next
section.

3D - Analysis of Conjugates of GSH with Mercury Species
Positive mode ESI-MS analysis of a GSH conjugate with Hg2+ by Burford, et al.
showed that, because of the divalent nature of Hg2+, two GSH molecules can combine
with one Hg2+ to produce a conjugate in which the most abundant peak appears at 815.1
m/z (23). Further research in this area by Feldmann, et al. also demonstrated that both
Hg2+ - GSH and CH3Hg+ - GSH conjugates, as well as conjugates of those two mercury

87

species with cysteine, could be detected by ESI-MS, with the characteristic mercury
isotopic fingerprint being easily observed in all cases (24). This isotopic fingerprint can
be observed in a GSH conjugate with C2H5Hg+ as well. An experiment carried out by our
research group which demonstrates this idea is described next.

Analysis of GSH Conjugates with three Mercury Species by nano-ESI-TOF-MS
Materials and Methods
An aqueous solution containing 0.0015% GSH (Sigma-Aldrich, St. Louis, MO),
0.1% formic acid (Sigma-Aldrich) , 50% Optima Acetonitrile (Fisher Scientific,
Pittsburgh, PA), 10 ppm Hg2+, 10 ppm CH3Hg+, and 10 ppm C2H5Hg+ (Applied Isotope
Technologies, Pittsburgh, PA) was prepared and analyzed by nano-ESI-TOF-MS. The
system used for detection was an Agilent 6220 TOF-MS with Chipcube Technology.
Analysis was carried out by direct infusion (Agilent infusion chip part number G424061002). The flow rate from the syringe pump (KD Scientific, Holliston, MS, model
number KDS 100 CE) was 70 µL/hour. The capillary voltage was 1525 V, the fragmentor
voltage was 225V, and the Nitrogen gas temperature was 325 oC. The run time was 1
minute.

Results and Discussion:
Information pertaining to the abundances of the isotopes in mercury, as well as a
visual display of the isotopic fingerprint, are shown in figure 7, which was taken from the
webelements.com website (25).
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Figure 7 – Mercury abundances and isotopic fingerprint (25)

The results from the simultaneous analysis of the three glutathione - mercury conjugates
are shown in Figure 8:
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538.1041 m/z

524.0873 m/z

CH3Hg+-GSH

C2H5Hg+-GSH

815.1457 m/z

Hg2+-GSH

Figure 8 – Simultaneous analysis of glutathione conjugated with three mercury species
using nano-ESI-TOF-MS

The GSH conjugates of all three mercury species were detected by nano-ESI-TOF-MS
with the characteristic mercury isotopic fingerprints clearly visible, just as with the
Feldmann study.

Extending GSH and Conjugate Quantification to IDMS and SIDMS by MALDI
As helpful as it is to perform qualitative analysis of glutathione conjugates with
these mercury species, quantitative analysis of these analytes would provide more
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information regarding the extent of one’s toxic burden of these mercury species, if
detected in the body. Additionally, the development of a quantitative method for
analyzing these conjugates using Matrix Assisted Laser Desorption Ionization (MALDI)MS, along with nano-ESI-TOF-MS would be useful as well, as both MALDI and ESI are
soft ionization ionization techniques. An experiment demonstrating the quantitative
analysis of a Hg2+ - GSH conjugate using IDMS is described next.

3E - Quantitative Analysis of Hg2+ - GSH Conjugate by nano-ESI-TOF-MS and
MALDI-TOF-MS using IDMS

There was a time when quantitation using MALDI-MS did not have wide
popularity, likely, in part, due to the difficulty of obtaining accurate and precise and
accurate quantitative results with a significantly fluctuating signal, as well as
irregularities in the analyte distribution in the spots on the MALDI target. More recently,
however, quantitation with MALDI-MS has become more prevalent. One factor
contributing to this shift has been the use of internal standards to correct for signal
fluctuation (26), which is also an advantage that the use of IDMS has. Our research
group has achieved quantitation of GSH conjugated to Hg2+ by both nano-ESI-TOF-MS
and MALDI-TOF-MS using IDMS. This experiment is described next.
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Materials and Methods
Quantitative IDMS with nano-ESI-TOF-MS
An aliquot of an aqueous 480.3 ppm natural abundant Hg2+ standard (~0.2000 g)
was spiked with ~ 0.2000 g of isotopically enriched 199Hg2+ (Applied Isotope
Technologies, Pittsburgh, PA) along with ~ 0.02000 g of ~50,000 ppm GSH, (SigmaAldrich, St. Louis, MO). ~1.6000 g of H2O and ~1.6000 g of Optima methanol (Fisher
Scientific, Pittsburgh, PA). This preparation of the IDMS sample was done in duplicate,
as were the IDMS blanks, which were prepared like the IDMS samples were except that
no natural abundant Hg2+ was added. These solutions were each analyzed six times
(n=12) by nano-ESI-TOF-MS with Agilent chipcube technology using the conditions
described for the analysis of the three mercury – GSH conjugates earlier in this chapter.

Quantitative IDMS with MALDI – TOF-MS
An aliquot of an aqueous 480.3 ppm natural abundant Hg2+ standard (~0.04800g)
was spiked with ~0.10000g of isotopically enriched 199Hg2+,(Applied Isotope
Technologies, Pittsburgh, PA) along with ~0.02000g of ~50,000 ppm GSH, ~0.05000g
of H2O, and ~0.07000g of ~5,000 ppm sinapic acid (Arcos Organics, Geel, Belgium) in
Optima methanol. This preparation of the IDMS sample was done in duplicate, as were
the IDMS blanks, which were prepared without natural abundant Hg2+. Each of these
solutions were spotted (2 μL) on a gold MALDI target (Agilent p/n G1972-60025) twelve
times (n = 24), and the spots were allowed to air dry at room temperature for three hours.
The target was analyzed using Agilent MALDI-TOF-MS using the following conditions:
wavelength of laser - 338 nm, Capillary Voltage - 2300 V, Fragmentor Voltage - 150 V,
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Gas Temperature: 325 oC, run time for each spot - 1 minute (the laser was applied to
several points on the spot over the course of 1 minute, and the average result over the
course of this 1 minute was obtained).

Additional steps
Along with both the nano-ESI and the MALDI runs were analyzed an additional
solution of natural abundant Hg2+ to determine the preliminary mass bias correction.
When GSH conjugates with Hg2+, two GSH molecules bind to one Hg2+, such that, in
positive mode ESI and MALDI, the most intense peak appears at ~815 m/z and the fourth
most intense peak appears at ~812 m/z. These peak intensities approximately (but not
exactly) quantitatively parallel the most abundant isotope in elemental Hg (the 202Hg
isotope) and the fourth most abundant isotope in elemental Hg (the 199Hg isotope),
respectively, in terms of isotope abundance. The 812/815 ratio was used for the IDMS
calculation. The preliminary mass bias correction was done with the understanding that
the initial answer obtained from it represented only an approximation of what the correct
Hg2+ value should be. An additional correction was made by analyzing a known 940.5
ppm Hg2+ solution using the nano-ESI method described earlier, and calculating the
answer by an IDMS algorithm developed in our laboratory. The actual known value
(940.5 ppm) was divided by the experimental value (1350 ppm) to obtain a supplemental
correction factor of 0.697. This supplemental correction factor was multiplied by the
initial experimental values from the nano-ESI and the MALDI analysis of the 480.3 ppm
Hg2+ solution to obtain the final experimental value.
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Results and Discussion
The results from the quantitative analysis of Hg2+ in GSH conjugate are shown in
Table 2
Concentration of Hg2+ in ppm in GSH
conjugate (reported to 95% C.I.)
nano-ESI-TOF-MS with IDMS
485 ± 18
MALDI-TOF-MS with IDMS
474 ± 73
Actual value
480.3
Table 2 – Comparison results from analysis of Hg2+ in glutathione conjugate
Method

conducted by IDMS-nano-ESI-TOF-MS and by IDMS MALDI-TOF-MS as compared to
the actual value.

The results for the concentration of Hg2+ from analysis of the Hg2+ - GSH conjugate in
the MALDI IDMS studies and the nano-ESI IDMS studies were in agreement with the
correct value within the 95% C.I. The precision achieved from both methods was better
than ± 20%. These results demonstrate the potential of performing quantitative analysis
of mercury-GSH conjugates using IDMS with both MALDI-MS and nano-ESI-MS.

3F - Conclusion
This chapter has described several applications involving of EPA Method 6800A
for the quantitation of analytes which are important to GSH metabolism. Of particular
importance was the finding, discovered by using EPA Method 6800A, that in the red
blood cell study, the autistic patients had higher red blood cell tGSH concentrations than
the healthy control patients did (p = 0.012), suggesting the possibility that the autistic
patients are making more GSH in response to possible elevated body burden of toxic
heavy metals, such as lead, antimony, aluminum, and cadmium. Results also showed that
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EPA Method 6800A could be used to quantitatively analyze a toxic heavy metal species
(Hg2+) with GSH in aqueous laboratory – prepared samples, indicating the potential for
performing such an analysis in a more complex matrix, such as blood or plasma. EPA
Method 6800A can be applied to monitor other analytes of metabolic importance as well,
such as substrates for enzymes for the purpose of assessing enzyme activity. An
experiment in which this different type of application was executed is described in the
next chapter.
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Chapter 4 - IDMS Analysis of GLA Activity in Tissue Lysates from Mice

Fabry’s disease, also called alpha-galactosidase-A (GLA) deficiency, is caused by
a lack of or faulty enzyme needed to metabolize lipids. It is one of a group of 44
lysasomal storage diseases (LSDs) characterized by the lack of or deficiency of enzyme
production. GLA deficiency results in the accumulation of glycosphingolipids with
terminal alpha- galactosyl residues, mainly globotriaosylceramide (Gb3) (1). Symptoms
include chronic pain, kidney impairment, and cardiac lipid build up (1). One in 117,000
people have this particular LSD disease (2). The GLA mechanism is shown below in
Figure 1(3):

Figure 1 – Human GLA Mechanism, taken from reference 3

In the above mechanism, Aspartate–170 functions as a nucleophile, and Aspartate-231
functions as an acid in the first step, then as a base in the second step.
Treatment options for Fabry’s disease include enzyme replacement therapy and
pain medication (4). Gene therapy for Fabry’s disease represents a potential alternative
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that can be less expensive over the long term than other treatments. An initial attempt to
develop a GLA gene therapy animal model was made using fluorescence equipment at
Allegheny Singer Research Institute with limited success due to the background
fluorescence from the tissue lysates (5). A collaboration between the Kingston Research
Group and the Allegheny Hospital (AH) was formed in 2009 and mass spectrometry was
introduced to take the place of the fluorescence measurements that were less sensitive
and accurate. The same samples used for the fluorescence experiments were reanalyzed
in our Center of Excellence by mass spectrometry and by our research group using IDMS
with nano-ESI-TOF-MS-MS, and the sensitivity and clarity of the results improved
significantly over the fluorescence data previously obtained by the Allegheny research
collaborators. These quantitative methods developed to analytically improve the
quantitative assessment of a mouse model and new salivary gland gene therapy
alternative may eventually advance the research into treatment of humans. The
development and application of these MS measurements is described next and lead to an
important contribution in medical research published in Human Gene Therapy (6).

Materials and Methods:

Initial work at Allegheny Singer Institute
Details about the mice that were used in the study, how the gene therapy was
administered, and how the tissues from the mice were processed are described in detail in
the referenced literature paper that was published in 2011 in Human Gene Therapy (6).
Briefly, control and knock out mice were obtained from Jackson Labs and brought to
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Allegheny Singer Institute. The mice were divided into four categories: 1. wild type –
normal mice (N = 8), 2. GLA gene deficient – lacked GLA gene (N = 14), 3. GLA gene
deficient, exposed to low dose of adenovirus particles (1 x 109 particles) with the GLA
gene (N = 8), and 4. GLA gene deficient, exposed to high dose of adenovirus particles (2
x 1010 particles) with the GLA gene (N = 14). Four days after initial exposure of the
treatment mice to the adenovirus particles, the mice were sacrificed, and their liver,
kidney, and brain tissues were harvested, after which these tissues were homogenized and
subjected to a GLA activity assay using fluorescence. Differences between gene
deficient and wild type samples were noticeable, but limited due to the background
fluorescence from tissue lysates. Because of this limitation, the initial manuscript of the
paper describing this project was rejected for publication. Over 100 mouse tissue samples
obtained by AH researchers were reanalyzed by IDMS in the Mass Spectroscopy Center
of Excellence and the paper was then rewritten around these higher quality analytical
measurements and resubmitted. New significance was emphasized and several land mark
findings were discovered that were new contributions to the research.

Quantitative Mass Spectrometry Development and Analysis at Duquesne University
In an attempt to increase the clarity of the GLA activity in the control and treated
mice analysis in the mouse tissue samples by IDMS eliminated the background
fluorescence problems experienced by the AG collaborators. Over 100 tissue samples
were reprocessed with the IDMS method, after the GLA assay was completed, subjected
to an SPE protocol, then analyzed by nano-ESI-Quadrupole time-of-flight Q(TOF)-MSMS.
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Details about the GLA assay and sample preparation for nano-ESI-QTOF-MSMS analysis are mentioned in the paper describing this research project, which was
published in Human Gene Therapy earlier this year with greater clarity of result
significance over the previous fluorescence data previously submitted and rejected for
publication (6). Briefly, the IDMS method was a modification of a procedure from Gelb
et al. (7) originally designed for blood spot GLA analysis. An outline for this procedure is
depicted in Figure 1 below:

Figure 1 – GLA assay described by Gelb, et al. (7)

In the procedure displayed in Figure 1, the sample is spiked with both natural
abundant synthetic substrate (referred to as “Fabry Substrate” in the figure) and
isotopically enriched synthetic standard (referred to as “Fabry Internal Standard” in the
figure). If the GLA enzyme is working properly, the ratio of the natural abundant
product (referred to as “Fabry Product” in the figure) to the isotopically enriched standard
should be higher than it would be if the enzyme were either absent or deficient. When
performing ESI-MS-MS on the natural abundant product and isotopically enriched
standard, the tertiary butoxycarbonyl (t-BOC) group can be fragmented off in the
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collision cell, resulting in the formation of the natural abundant product ion (384 m/z)
and the isotopically enriched product ion (389 m/z).
In the collaborative project between Allegheny Research Institute and our
research group, for the GLA assay, 15 µL of the assay solution (3.33 mmol/L of GLA-S
(Fabry substrate in figure 1), 6.67 µmol/L of GLA-IS (Fabry Internal Standard in figure
1), 160 mmol /L ,N- Acetylgalactosamine, and 0.142 mol/L sodium acetate, pH 4.6) and
10 µL of tissue homogenate were added to a 1.7 mL centrifuge tube, centrifuged at 1350
x g for 1 minute, and then incubated at 37oC for 20 minutes. After incubation, the tube
was briefly centrifuged, then the reaction was quenched by adding 100 µL of ethyl
acetate/methanol 1:1. 400 µL of ethyl acetate, followed by 400 µL of H2O were added
and mixed with up and down aspiration in the pipette tip. The tube was then centrifuged
at 1350 x g for 5 minutes to get the two phase separation. 300 µL of the top organic layer
was transferred to a clean 1.7 mL microcentrifuge tube.

Additional Sample Cleanup
Further sample preparation was carried out by our research group at Duquesne to
optimize detection of the analytes by nano-ESI-TOF-MS-MS. This protocol involved
SPE using hydrophilic interaction liquid chromatography (HILIC). The SPE column
used was a UCT (Bristol, PA) diol column, with 200 mg of sorbent and a 1 mL volume.
The steps used in the SPE procedure are described next:

Step 1 - Condition SPE column with 1.8 mL of acetonitrile/H2O 80/20
Step 2 - Add 150 µL from the 300 µL ethyl acetate solution to the column
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Step 3 - Run 1 mL of acetonitrile/H2O through the column and collect eluent
Step 4 - Add 2 µL of 90% formic acid to the eluent to help with ionization

nano-ESI-QTOF-MS-MS conditions
The conditions used for the analysis were as follows: system – Agilent chipcube
with infusion chip (Agilent part number G4240-61002) and 6530 QTOF, syringe pump
flow rate – 70 µL/hr, capillary voltage – 1450V, fragmentor voltage – 150V, collision
cell – 20V, gas temperature – 325oC, drying gas flow – 4L/min, run time – 1 minute.
Analytical runs were completed in triplicate.

Results and Discussion:
An example MS/MS spectrum from a gene deficient sample is shown below in Figure 2:

•

Figure 2 - The peak at ~384.2279 m/z is the product ion from the natural abundant
enzyme-substrate reaction product (theoretical m/z = 384.2282); the one at ~
389.2584 m/z is the product ion from the isotopically enriched form of the analyte
(theoretical m/z = 389.2595)
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An example MS/MS spectrum from a wild type sample is shown below in Figure 3:

•

Figure 3 - The peak at ~384.2283 m/z is the product ion from the natural abundant
enzyme-substrate reaction product (theoretical m/z = 384.2282); the one at ~
389.2584 m/z is the product ion from the isotopically enriched form of the analyte
(theoretical m/z = 389.2595)

Figure 4 on the next page shows the comparison between the results from the fluorescent
assay and those from the isotope dilution - MS/MS analysis:
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Figure 4 – Results from both the fluorescent assay and the MS/MS assay.

The florescence spectroscopy assay does not have the fidelity to distinguish between the
low dose mice, and a lack of quantitative fidelity diminished the significance of the tissue
samples. In direct comparison, the IDMS data was able to show the differences in the
animal model.
The clarity of the results using the isotope dilution – MS/MS analytical method
demonstrated that the fluorescence method lacked the fidelity and quantitative accuracy
to dramatically emphasize the significance of the animal model. As a result of these
improved analytical results being obtained, the paper for this project was resubmitted for
publication with the MS/MS results, and the publication was accepted (6).
For future work, research is ongoing to develop a gene therapy method without
having to use a viral delivery system. The method involves sonication through the
animal’s salivary gland and will be evaluated using the MS/MS method described in this
chapter.

Conclusion
This chapter described experiments involving the application of IDMS TOF-MS
for quantitative analysis of enzyme activity. Results showed that this method provided
superior methodology for enzyme activity analysis compared to more conventional
methods, such as the fluorescence spectroscopy assay mentioned earlier.
The use of TOF-MS, being a high resolution method, with mass accuracy usually
within ± 5 ppm, can also be used to confirm results for the identification of compounds
obtained from other analytical methods, such as 1HNMR. GC/MS, which uses electron
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ionization at 70 eV and yields mass spectrometry data with virtually compound-unique
fragmentation patterns, can also be used to complement 1HNMR results. This application
of TOF-MS and GC/MS is described in the next chapter.
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Chapter 5 – Mass Spectrometry Service Analysis

For organic and medicinal chemists to get their research published, they need to
demonstrate that the synthetic schemes for their compounds of interest are successful by
confirming the identity of the final products in those synthetic schemes by using at least
two independent analytical methods. If one wants to publish in the Journal of Organic
Chemistry (JOC), for example, one needs to provide both 1HNMR and 13CNMR results,
along with results from either HRMS analysis or elemental analysis (1). For HRMS
analysis of compounds below 1,000 G/mol, this journal considers results within 0.003
m/z of the theoretical value to be considered acceptable. This journal also allows for
theoretical values to include ones in which atoms are added to the analytes’ ions,, such as
when sodium adducts are formed.
At Duquesne University (DU), first a walk up use of the Agilent TOF was
attempted for groups wishing to use the mass spectrometer to do their own HRMS data
for their publications. This experiment proved to be unsuccessful as the students did not
take the care to prepare the sample properly, filter them, or dilute them, and the
instrument frequently had to be repaired as a result. This practice was abandoned. It was
then reformulated to have these graduate students from these synthetic laboratories
submit their samples to an experienced analytical chemist who, initially, was Dr.
Stephanie Wetzel from the Chemistry and Biochemistry Department at Duquesne
University and, later on, after receiving training from Dr. Wetzel, was the author of this
dissertation. The analyst would manage the final preparation and the instrument oversight
and analyses. This proved to be successful for over three years, and an experiment was
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commenced to see how the support of other laboratories would proceed under these
conditions and what would be the use and need and talent needed to successfully create
an HRMS service laboratory system. This was done for free as an experiment in the
Department of Chemistry and Biochemistry on the NSF MRI granted instrumentation
that had been received and completed in its construction in 2006 through 2011.
For these years, the Kingston Research Group has been supporting the chemistry
faculty and the pharmacy faculty by providing these services using the NSF granted
instrument. The author of this dissertation has been the analyst in recent years performing
these analyses and has been on a Research Assistant (RA) funded in the Professor
Kingston performing these analyses as an experiment of service to the DU synthetic
chemists. These in-house HRMS analyses have been a free service for research groups in
both the Chemistry and Pharmacy departments and the use of the facility has grown to
over 200 HRMS samples per year. The monetary value of this service can be seen as
considerable given the fact that other universities, such as the University of Iowa, charge
their within-university staff for HRMS analysis. The rate at the University of Iowa for
HRMS analysis, for example, is $59 per sample (2). At Duquesne University, just in 2010
alone, approximately 200 HRMS samples were analyzed for no charge for research
groups in the Chemistry and Pharmacy departments. Had the pricing system of the
University of Iowa been in place at Duquesne, the HRMS samples analyzed in 2010 for
the Duquesne research groups would have cost over $11,000. This represents a
significant savings for the university.
When samples are submitted to the analyst at Duquesne for HRMS analysis, the
samples come with a submission form which gives the analytical chemist information as
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to what analyte m/z values to look for. Included in this submission form is also a section
where the proposed structure of the compound is to be given. This helps the analyst
because it provides information regarding what functional groups are present and how
polar the compound is, which, in turn, enables the analytical chemist to decide how to
best analyze the sample. This chapter has been prepared to both document the
development of this capability and to permit this service should this service be continued.
A description of the structure the organic molecule including polarity is essential
for the analytst to determine how best to analyst the sample. For example, polar
compounds with amines are good candidates for positive mode ESI-MS analysis, whereas
compounds of relatively low molecular weight (~1,000 Dalton or below) and moderately
low to intermediate polarity would be good candidates for Atmospheric Pressure
Chemical Ionization (APCI)-MS analysis (3). According to Dr. John Greaves, who runs
the HRMS laboratory at the University of California at Irvine, there are some compounds
that are so nonpolar that even APCI-MS will not work (4). An example of a case study
involving the successful analysis of such a compound by the analyst at Duquesne will be
discussed later in this chapter.
Most (about 90%) of the compounds submitted thus far to the analyst at
Duquesne can be analyzed using positive mode nano-ESI-TOF-MS by direct infusion
using the Agilent equipment described in chapters 3 and 4.Typically, the compounds are
dissolved in either Acetonitrile or Methanol (high purity brand, such as Optima from
Fisher Scientific, Pittsburgh, PA), and, often, the sodium adduct is the most abundant ion
detected due to the presence of sodium in the glassware used by the synthetic chemists.
Although a reasonable analyte concentration for the HRMS analysis would be about 10
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ppm, usually, when compounds are submitted, no information whatsoever is given to the
analyst as to what the concentration is. This renders it necessary for the analytical
chemist, as a precautionary measure, to dilute the sample at least 100-fold to minimize
the likelihood of overloading the instrument with sample. If it turns out that the
concentration of the diluted sample is too low, all one has to do is use a higher
concentration, and only a few minutes are lost. If, however, this precautionary measure is
not followed, one runs the risk of overloading the instrument with a solution with a
concentration that is too high (usually over 100 ppm), after which can take several hours
to flush the compound out of the system.
If the analyte is not detected during the HRMS analysis, there can be several
possible reasons. Some of these possibilities are given below:
-

The concentration was too low.

-

The container and/or HRMS form was mislabeled.

-

The solvent that the compound was dissolved in reacted with the compound.

-

The proper NMR analysis was not completed before sample submission.

-

The compound decomposed while waiting to be analyzed.

-

The appropriate source was not used (e.g. ESI vs. APCI)

-

The appropriate mode was not used (positive vs. negative)

If the analyte is not detected by the analyst, the analytical chemist who performed the
HRMS analysis can communicate with the synthetic chemist who submitted the sample
to determine what, if any, alternative methods can be used. The following three case
studies represent real examples of situations in which the initial HRMS analysis of the
submitted samples with the usual positive mode nano-ESI-TOF-MS was not successful,
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but eventually the desired results were obtained by the analytical chemist. No chemical
structures will be shown due to the proprietary nature of the compounds that were
submitted, but general descriptions of the compounds will be given.

Case # 1
A sample was submitted by a person from Dr. Fleming’s research group. The
compound seemed to be present based upon NMR analysis, but the person who submitted
the sample also mentioned that it was sensitive to oxidation. According to the proposed
structure that was given to the analytical chemist, the sample was a low molecular weight
(below 500 amu) compound with a sulfur atom. When the sample was initially analyzed
using positive mode nano-ESI-TOF-MS, the analyte of interest was not detected. Upon
further examination however, it was noticed that there were three peaks detected which
were about 16 m/z units higher than their corresponding expected [M+H] +, [M+Na]+, and
[M+K]+ peaks. When the proposed structure was modified to include an additional
oxygen atom, the experimental m/z values were in agreement with the theoretical m/z
values to within 10 ppm error of the theoretical mass. The successful detection of the
modified compound enabled the person from Dr. Fleming’s group who submitted the
compound to publish his work in the literature.

Case # 2
A sample was submitted by a person from Dr. Basu’s research group which was
of moderately low polarity. An initial attempt to analyze the sample by positive mode
nano-ESI-TOF-MS was not successful. It was hypothesized that the polarity of the
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sample was too low for ESI-MS analysis. Positive mode APCI-TOF-MS was used
instead. As a result, the moderately nonpolar compound was successfully detected.

Case # 3
A compound with a long hydrocarbon chain, an oxygen atom, and several fluorine
atoms was submitted to the analytical chemistry staff by a person from Dr. Janjic’s group
from the Pharmacy Department. The compound seemed to be present according to the
NMR results, but attempts to analyze the sample by both positive and negative mode
nano-ESI-TOF-MS were not successful (according to Dr. Schilling from the University
of Illinois at Chicago, negative mode can be used with the Agilent Chipcube system
provided that the capillary voltage remains at or below 1600V (5)). Dr. Janjic sent the
sample to outside laboratories for analysis, and the sample was still not detected by any
of the commercial laboratories. At the 2010 ASMS meeting in Salt Lake City, Dr. John
Greaves, who runs the HRMS laboratory at the University of California at Irvine, after
being given a general description of the compound without revealing the structure,
surmised that the compound was so nonpolar that even APCI-MS would not ionize the
compound. He mentioned that his laboratory had a high resolution GC/MS system and
that the sample could be sent to him for analysis, but he suggested that the analyst at
Duquesne analyze it first on low mass resolution GC/MS at Duquesne. After successfully
detecting it with the low resolution GC/MS at Duquesne, the sample could be sent to him
for high mass resolution GC/MS analysis. This analysis was carried out by Becky
Wagner, one of the analytical chemistry graduate students at Duquesne. The following
conditions were used for the analysis:
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System – Agilent 6890N GC coupled with Agilent 5973 MS



Sample dissolved in 2-propanol (concentration – 60 ppm)



Molecular weight: 432 g/mol



1 µL injection volume



Injector: 250oC



Start oven → 75oC, hold 1 minute



10oC/min up to 275oC, hold for 4 minutes



Column → HP-5 MS



Transfer line temperature: 280oC



4 minute solvent delay



Range: 40 m/z – 500 m/z

The GC chromatogram is shown in Figure 1 below. The analyte peak of interest was
detected at ~ 10.5 minutes:
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Figure 1 – GC chromatogram of sample submitted by Dr. Janjic’s group

The MS fragmentation pattern from the peak at ~ 10.5 minutes in the chromatogram
(from 240 m/z upward) is shown in Figure 2 below:

Figure 2 – MS fragmentation pattern from 240 m/z upward from peak detected at ~ 10.5
minutes in the GC chromatogram.
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In the fragmentation pattern in Figure 2, the parent ion was successfully detected
at 432 m/z. The peak at 403 m/z represents the loss of an ethyl group (C 2H5 → 29 m/z).
There are several other peaks about 14 m/z units apart, representing the loss of successive
methylene groups (CH2), which is common in the GC/MS analysis of compounds with
long-chain hydrocarbon groups. The continuation of this fragmentation pattern with the
loss of CH2 groups can be seen from 40 m/z to 240 m/z shown in Figure 3, which is
shown below:

Figure 3 - MS fragmentation pattern from 40 m/z – 240 m/z from peak detected at ~ 10.5
minutes in the GC chromatogram
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The results from the GC/MS analysis were consistent with what was expected for the
compound submitted by the person from Dr. Janjic’s group.
In order for successful HRMS analysis to occur, proper communication between
the person submitting the sample and the person analyzing the sample must exist. The
tools available to the analytical chemist at Duquesne are many, but no one instrumental
method consisting of a single ionization source is sufficiently robust to detect every type
of analyte submitted, as the case studies in this chapter demonstrate. Skill and experience
several ionization systems are necessary for the analyst. Success comes as a result of
teamwork, and it is a requirement for the analytical chemist performing the HRMS
analysis and the organic/medicinal chemist submitting the samples for HRMS analysis to
exchange necessary information with each other for the program to work properly. The
analyst can not do the job if the synthetic/medicinal chemist does not provide the
necessary information, such as what solvent the sample is dissolved in, whether or not the
compound of interest has been successfully analyzed by 1HNMR and/or 13C NMR, and
how to best store the sample until analysis. To assist with this submission process, an
updated submission form has been developed that has areas where the synthetic chemist
can submit the necessary information. It was found that safety information was especially
necessary, and appropriate other information and instructions were necessary as well .
This form was developed as a result of this several years of experiment and iteration, and
is attached as an appendix to the dissertation after this chapter.
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Appendix – Updated draft of Official HRMS submission form
(Begin form)
Updated Official Submission Form for HRMS Analysis

Faculty member’s name (printed) _____________________________
Faculty member’s signature __________________________
Student’s name (printed) _______________________________
Student’s signature _______________________________
Compound name _________________________
Date submitted __________________________
Molecular weight _______________________
[M + H]+ theoretical m/z value __________________
[M +Na]+ theoretical m/z value __________________
[M + K]+ theoretical m/z value ___________________
Solvent that the sample is dissolved in if submitted in solution form (use either
acetonitrile or methanol) _________________
Concentration of sample in units of parts per million (ppm) ___________________
Molecular formula of compound _________________________
Safety precautions that need to be taken with the sample:
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Structure of compound (draw below):

Questions about sample (response for each must be “yes” before submission for HRMS
analysis)
1. Has the sample been successfully identified by 1 H NMR (and, if necessary, 13C NMR)
? (yes/no)
2. Has the sample been purified to the point where ONLY the analyte peaks show up in
the NMR (in other words, no peaks from, for example, excess starting material) (yes/no)
3. Is HRMS analysis necessary as the final step before publication? (yes/no)

General comments:
Samples submitted merely to monitor the progress of reactions will not be
accepted unless, in extraordinarily rare cases, all other means to do so, such as normal
phase thin layer chromatography, reversed phase thin layer chromatography, NMR,
GC/MS, or other methods, have been exhausted. Providing the structure will help the
person performing the HRMS analysis to determine how best to analyze the sample and
will, thus, speed up the process. Generally, for compounds of relatively high polarity to
intermediate polarity, nano-ESI-TOF-MS will be used. For samples that are of
intermediate polarity or are relatively nonpolar, APCI-TOF-MS will be used.
(End of form)

123

Chapter 6 – Conclusion

This dissertation has described research projects involving applications of EPA
6800A to new areas, such as toxicology, biomarker discovery, and enzyme activity
analysis. In closing, taking a step back and looking at the big picture, one can see how
these three applications fit together. The speciation of toxic heavy metals, such as
mercury, in biological matrices, such as blood, is related to the analysis of possible
autism biomarker, such as GSH, in those same biological matrices, as the concentration
of GSH in red blood cells appears to be affected by the body burden of toxic heavy
metals (1). Toxic heavy metals can also have an impact on enzyme activity via inhibition,
and it may be that some of the enzymes being inhibited are ones which contribute to GSH
synthesis, as it has been suggested that GSH synthesis can be inhibited by mercury;
conversely, toxic metals other than mercury may stimulate GSH synthesis (1).
The process of answering one question leads to the formation of more questions
such that, no matter how many questions one answers, there will always be further
questions left unanswered. This dissertation is no exception to that rule. One question that
needs to be answered pertains to why the autistic patients in our red blood cell study have
higher red blood cell tGSH values than their corresponding controls. It could be that their
bodies are making more GSH in response to a greater body burden of toxic heavy metals
other than mercury, but further research is needed to determine this, and EPA Method
6800A can be used to address this issue by using it for the analysis of heavy metals in the
red blood cell patients. This work is currently being carried out by my colleague, Greg
Zinn, a graduate student at Duquesne University. Another question that needs to be
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addressed more thoroughly pertains to what the metabolic fate of Thimerosal in the body
is. C2H5Hg+, a component of Thimerosal, can interconvert with other mercury species
during sample preparation and, as was presented in this dissertation, EPA Method 6800A
can be used to correct for these interconversions; hence, EPA Method 6800A would be
the ideal method of choice to address this question as well. An additional question that
needs to be addressed concerns which toxic heavy metals are being bound to which
biomolecules and in what amounts. The work described in this dissertation pertaining to
the analysis (qualitative and quantitative) of GSH conjugates with mercury species in
aqueous solutions provides a starting point, but further work is needed in this area.
Ideally, one would like to detect the heavy metal bound to the biomolecule by mass
spectrometry using a soft ionization method, such as ESI or MALDI, and it would be best
for one to obtain quantitative, rather than just qualitative results. EPA Method 6800A can
also be used for this area of research.
In closing, it is essential for scientists to be open to new ideas. Over the centuries,
many scientific ideas that were initially met with rejection were eventually accepted. One
such example occurred with an astrophysicist by the name of Subrahmanyan
Chandrasekhar. In the 1930s, as a young scientist, he proposed that, if a collapsing star
has a mass above a certain limit (known today as the Chandrasekhar limit), the star would
collapse down to what is today known as a black hole. His supervisor at the time, Sir
Arthur Eddington, strongly rejected this idea, as did Albert Einstein; nevertheless,
Chandrasekhar’s idea was eventually shown to be correct, and his work in this area
contributed to his winning the Nobel Prize in 1983 (2). Another example occurred with a
rocket scientist by the name of Dr. Robert Goddard. In 1920, he proposed that it would
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one day be possible to send a rocket to the moon. This idea was met with rejection by
many in the scientific community, as well the popular culture. The New York Times
newspaper ridiculed this idea. In 1969, 49 years later, a day after Apollo 11 left for the
moon, the New York Times retracted its statement (3). An additional example occurred
with my research advisor at Duquesne, Dr. H.M. “Skip” Kingston, when he proposed that
it would be possible to perform chemistry experiments (extraction, digestion, synthesis,
etc.) in the microwave which would prove to be more efficient than the more classical
methods. This idea was initially met with rejection. Some of his colleagues jokingly
referred to him as “Betty Crocker.” (4). Despite this, the microwave chemistry concept
eventually gained acceptance in the scientific community, with many publications
describing the successful use of this methodology being made, including this one.
In short, a good scientist has the humility to recognize that, no matter how much
one learns, there is always more to learn. No matter how much one grows, there is always
room for further growth.
St. Albert the Great, patron saint of scientists, pray for us.
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